name	description	sourcemtoverride	samplemtoverride	region	env_feature	country	host_common_name	body_habitat	body_site	body_product	host_subject_id	Sex	Collection date	sample_type	Clinical Status	Forced Expiratory Volume (FEV1) percentage	Virology result	Age (days)	Age (years)	Forced Expiratory Volume (FEV1) liter	Azithromycin	Tobramycin	Colistin	Aztreonam	Dornase	F508del-CFTR genotype	Mutation 1	Mutation 2	Visit Number	Adenovirus	Coronavirus	Coronavirus 229E	Coronavirus HKU1	Coronavirus NL63	Coronavirus OC43	Enterovirus	Human metapneumovirus	Influenza	Influenza A 2009	Rhinovirus	Respiratory syncytial virus	parainfluenza 3	methicillin resistant Staphylococcus aureus (MRSA)	methicillin sensitive Staphylococcus aureus (MSSA)	MSSA (prelim)	Citrobacter	Staphylococcus	Mixed Commensal Flora (MCF)	MCF (prelim)	Pseudomonas	Pseudomonas (prelim)	Pseudomonas putida	Pseudomonas luteola	Klebsiella pneumoniae	Streptococcus pneumoniae	Haemophilus influenza	Chryseobacterium indologenes	Acinetobacter lwoffi	Serratia	Burkholderia cenocepacia	Pseudomonas (nonmucoid)	Pseudomonas (mucoid)	Achromobacter	Achromobacter xyloxidans	Escherichia coli	Haemophilus	Stenotrophomonas	Chryseobacterium	Klebsiella	Klebsiella oxytoca	Candida albicans	Aspergillus	Acinetobacter	Burkholderia multivorans	Serratia liquifaciens	Serratia marcescens	Shewanella putrifaciens	Citrobacter freundii	Neisseria meningitidis	Nocardia	Mycobacterium abcessus	Enterobacter	Streptococcus pyogenes
SRS6977292.SRR12184718	ECOCF0001, visit 1			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0001	Female	2/23/10	Sputum	Recovery (within 1 month after stopping antibiotics for exacerbation)			6303	17.3		Y	Y	N	N	Y				1																																																						
SRS6977301.SRR12184709	ECOCF0002, visit 3			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0002	Male	10/5/10	Sputum	Baseline	118		7382	20.2	4.92	Y	Y	N	N	Y	other	G85E	I1234V	3																																																						
SRS6976525.SRR12184307	ECOCF0018, visit 3			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0018	Female	6/28/10	Sputum				6604	18.1		N	N	N	N	Y	homozygous	F508del	F508del	3																																																						
SRS6976528.SRR12184304	ECOCF0018, visit 4			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0018	Female	11/29/10	Oral swab	Exacerbation (treatment with antibiotics)	79		6758	18.5	2.51	Y	N	N	N	Y	homozygous	F508del	F508del	4																																																						
SRS6976529.SRR12184303	ECOCF0019, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0019	Female	9/21/10	Oral swab	Baseline	83		6382	17.5	2.74	N	N	N	N	Y	homozygous	F508del	F508del	1																																																						
SRS6977302.SRR12184708	ECOCF0002, visit 4			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0002	Male	1/25/11	Sputum	Baseline	121		7494	20.5	5.03	Y	Y	N	N	Y	other	G85E	I1234V	4																																																						
SRS6976530.SRR12184302	ECOCF0020, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0020	Female	6/15/10	Oral swab	Recovery (within 1 month after stopping antibiotics for exacerbation)	90		4839	13.2	2.32	N	N	N	N	N	other	W1282X	W1282X	1																																																						
SRS6976531.SRR12184301	ECOCF0020, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0020	Female	10/17/11	Oral swab	Recovery (within 1 month after stopping antibiotics for exacerbation)			5328	14.6		N	N	N	N	N	other	W1282X	W1282X	2																																																						
SRS6976532.SRR12184300	ECOCF0020, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0020	Female	2/22/12	Oral swab	Baseline			5456	14.9		N	N	N	N	N	other	W1282X	W1282X	3																																																						
SRS6976533.SRR12184299	ECOCF0021, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0021	Female	6/1/10	Oral swab	Baseline	94		4594	12.6	2.23	N	N	N	N	N	heterozygous	R31C	F508del	1																																																						
SRS6976560.SRR12184272	ECOCF0021, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0021	Female	8/24/10	Oral swab	Baseline	99		4678	12.8	2.4	N	N	N	N	N	heterozygous	R31C	F508del	2																																																						
SRS6976561.SRR12184271	ECOCF0021, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0021	Female	7/19/11	Oral swab	Baseline	106		5007	13.7	2.67	N	N	N	N	N	heterozygous	R31C	F508del	3																																																						
SRS6976562.SRR12184270	ECOCF0022, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0022	Male	3/2/10	Oral swab	Baseline	104		4205	11.5	2.99	N	N	N	N	Y	heterozygous	F508del	3849+10kbC->T	1																																																						
SRS6977303.SRR12184707	ECOCF0002, visit 5			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0002	Male	10/18/11	Sputum	Exacerbation (no treatment)	115		7760	21.2	4.81	Y	Y	N	N	Y	other	G85E	I1234V	5																																																						
SRS6976563.SRR12184269	ECOCF0022, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0022	Male	7/6/10	Oral swab	Baseline	114		4331	11.9	3.46	N	N	N	N	Y	heterozygous	F508del	3849+10kbC->T	2																																																						
SRS6976564.SRR12184268	ECOCF0022, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0022	Male	9/28/10	Oral swab	Baseline	110		4415	12.1	3.47	N	N	N	N	Y	heterozygous	F508del	3849+10kbC->T	3																																																						
SRS6976565.SRR12184267	ECOCF0022, visit 4			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0022	Male	12/21/10	Oral swab	Baseline	115		4499	12.3	3.68	N	N	N	N	Y	heterozygous	F508del	3849+10kbC->T	4																																																						
SRS6976566.SRR12184266	ECOCF0023, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0023	Male	3/2/10	Oral swab	Baseline	97		4002	11	2.78	N	N	N	N	N	heterozygous	F508del	R117C	1																																																						
SRS6976567.SRR12184265	ECOCF0023, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0023	Male	8/3/10	Oral swab	Baseline	95		4156	11.4	2.79	N	N	N	N	N	heterozygous	F508del	R117C	2																																																						
SRS6976568.SRR12184264	ECOCF0023, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0023	Male	11/9/10	Oral swab	Baseline	98		4254	11.6	2.75	N	N	N	N	N	heterozygous	F508del	R117C	3																																																						
SRS6976569.SRR12184263	ECOCF0023, visit 4			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0023	Male	6/14/11	Oral swab	Baseline	92		4471	12.2	2.89	N	N	N	N	N	heterozygous	F508del	R117C	4																																																						
SRS6976571.SRR12184261	ECOCF0023, visit 5			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0023	Male	10/11/11	Oral swab	Baseline			4590	12.6		Y	N	N	N	N	heterozygous	F508del	R117C	5																																																						
SRS6977304.SRR12184706	ECOCF0003, visit 1			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0003	Female	2/23/10	Sputum	Baseline	79		7279	19.9	2.59	Y	Y	N	N	Y	homozygous	F508del	F508del	1																																																						
SRS6976574.SRR12184258	ECOCF0024, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0024	Male	3/29/10	Oral swab	Recovery (within 1 month after stopping antibiotics for exacerbation)			5310	14.5		Y	N	N	N	Y	other	W1282X	W1282X	1																																																						
SRS6976575.SRR12184257	ECOCF0024, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0024	Male	5/20/10	Oral swab	Baseline	39		5362	14.7	1.4	Y	N	N	Y	Y	other	W1282X	W1282X	2																																																						
SRS6976576.SRR12184256	ECOCF0024, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0024	Male	7/6/10	Oral swab	Baseline	51		5409	14.8	1.86	Y	N	N	Y	Y	other	W1282X	W1282X	3																																																						
SRS6976577.SRR12184255	ECOCF0024, visit 4			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0024	Male	8/13/10	Oral swab	Baseline	35		5447	14.9	1.45	Y	N	N	Y	Y	other	W1282X	W1282X	4																																																						
SRS6976578.SRR12184254	ECOCF0024, visit 5			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0024	Male	12/3/10	Oral swab	Exacerbation (no treatment)	32		5559	15.2	1.18	Y	N	N	Y	Y	other	W1282X	W1282X	5																																																						
SRS6976572.SRR12184260	ECOCF0024, visit 6			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0024	Male	12/17/10	Sputum	Exacerbation (treatment with antibiotics)	31		5573	15.3	1.15	Y	N	N	N	Y	other	W1282X	W1282X	6																																																						
SRS6976573.SRR12184259	ECOCF0024, visit 7			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0024	Male	7/19/11	Sputum	Exacerbation (no treatment)	26		5787	15.8	1.04						other	W1282X	W1282X	7																																																						
SRS6976579.SRR12184253	ECOCF0024, visit 8			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0024	Male	3/16/12	Oral swab	Baseline	25		6028	16.5	1.05	Y	Y	N	N	Y	other	W1282X	W1282X	8																																																						
SRS6976580.SRR12184252	ECOCF0024, visit 9			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0024	Male	5/15/12	Oral swab	Baseline	27		6088	16.7	1.13	Y	Y	N	N	Y	other	W1282X	W1282X	9																																																						
SRS6977305.SRR12184705	ECOCF0003, visit 2			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0003	Female	10/12/10	Sputum	Baseline	79		7510	20.6	2.57	Y	Y	N	N	Y	homozygous	F508del	F508del	2																																																						
SRS6976582.SRR12184250	ECOCF0026, visit 1			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0026	Female	3/9/10	Sputum	Baseline	41		3965	10.9	0.79	Y	Y	N	N	Y				1																																																						
SRS6976583.SRR12184249	ECOCF0027, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0027	Male	3/9/10	Oral swab	Baseline	104		2351	6.4	1.12	N	N	N	N	N	other	R334W		1																																																						
SRS6976588.SRR12184244	ECOCF0027, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0027	Male	6/18/10	Oral swab	Baseline	111		2452	6.7	1.25	Y	N	N	N	N	other	R334W		2																																																						
SRS6976589.SRR12184243	ECOCF0027, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0027	Male	12/29/11	Oral swab	Baseline	100		3011	8.2	1.44	N	N	N	N	Y	other	R334W		3																																																						
SRS6976590.SRR12184242	ECOCF0028, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0028	Female	6/21/11	Oral swab	Baseline	126		6010	16.5	3.88	N	N	N	N	N				1																																																						
SRS6976591.SRR12184241	ECOCF0029, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0029	Male	3/9/10	Oral swab	Baseline			728	2		N	N	N	N	N	heterozygous	F508del	Other	1																																																						
SRS6976592.SRR12184240	ECOCF0029, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0029	Male	6/8/10	Oral swab	Baseline			819	2.2		N	N	N	N	N	heterozygous	F508del	Other	2																																																						
SRS6976593.SRR12184239	ECOCF0029, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0029	Male	10/26/10	Oral swab	Baseline			959	2.6		N	N	N	N	N	heterozygous	F508del	Other	3																																																						
SRS6976594.SRR12184238	ECOCF0029, visit 4			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0029	Male	2/21/12	Oral swab	Baseline			1442	3.9		N	N	N	N	N	heterozygous	F508del	Other	4																																																						
SRS6976595.SRR12184237	ECOCF0030, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0030	Male	3/9/10	Oral swab	Baseline			301	0.8		N	N	N	N	N	heterozygous	F508del	R553X	1																																																						
SRS6976597.SRR12184235	ECOCF0030, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0030	Male	4/23/10	Oral swab	On Antibiotics No Exacerbation			346	0.9		N	N	N	N	N	heterozygous	F508del	R553X	2																																																						
SRS6976598.SRR12184234	ECOCF0030, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0030	Male	7/13/10	Oral swab	Baseline			427	1.2		N	N	N	N	N	heterozygous	F508del	R553X	3																																																						
SRS6976599.SRR12184233	ECOCF0030, visit 4			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0030	Male	10/5/10	Oral swab	Baseline			511	1.4		N	N	N	N	N	heterozygous	F508del	R553X	4																																																						
SRS6976600.SRR12184232	ECOCF0030, visit 5			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0030	Male	1/25/11	Oral swab	Baseline			623	1.7		N	N	N	N	N	heterozygous	F508del	R553X	5																																																						
SRS6977306.SRR12184704	ECOCF0004, visit 1			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0004	Female	2/23/10	Sputum	Baseline	87		6415	17.6	2.53	Y	Y	N	N	Y	heterozygous	F508del	Other	1																																																						
SRS6976602.SRR12184231	ECOCF0030, visit 6			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0030	Male	2/22/11	Oral swab	Exacerbation (treatment with antibiotics)			651	1.8		N	N	N	N	N	heterozygous	F508del	R553X	6																																																						
SRS6976601.SRR12184230	ECOCF0030, visit 7			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0030	Male	6/7/11	Oral swab	Baseline			756	2.1		N	N	N	N	N	heterozygous	F508del	R553X	7																																																						
SRS6976603.SRR12184229	ECOCF0031, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0031	Female	3/9/10	Oral swab	Baseline	92		3503	9.6	1.7	N	Y	N	N	N	heterozygous	F508del	V520F	1																																																						
SRS6976604.SRR12184228	ECOCF0031, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0031	Female	5/20/10	Oral swab	Baseline	92		3575	9.8	1.75	Y	Y	N	N	Y	heterozygous	F508del	V520F	2																																																						
SRS6976605.SRR12184227	ECOCF0031, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0031	Female	8/16/11	Oral swab	Baseline			4028	11		N	N	N	N	N	heterozygous	F508del	V520F	3																																																						
SRS6976609.SRR12184223	ECOCF0032, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0032	Female	3/9/10	Oral swab	Baseline	90		4193	11.5	2.27	Y	Y	N	N	Y	homozygous	F508del	F508del	1																																																						
SRS6976610.SRR12184222	ECOCF0032, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0032	Female	4/29/10	Oral swab	Recovery (within 1 month after stopping antibiotics for exacerbation)	87		4244	11.6	2.24	N	N	N	N	Y	homozygous	F508del	F508del	2																																																						
SRS6976611.SRR12184221	ECOCF0032, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0032	Female	6/15/10	Oral swab	Baseline	81		4291	11.7	2.13	N	N	N	N	Y	homozygous	F508del	F508del	3																																																						
SRS6976612.SRR12184220	ECOCF0032, visit 4			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0032	Female	7/6/10	Oral swab	Baseline	74		4312	11.8	1.94	Y	N	N	N	Y	homozygous	F508del	F508del	4																																																						
SRS6976613.SRR12184219	ECOCF0032, visit 5			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0032	Female	8/24/10	Oral swab	Baseline	77		4361	11.9	2.01	Y	N	N	N	Y	homozygous	F508del	F508del	5																																																						
SRS6977309.SRR12184701	ECOCF0004, visit 3			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0004	Female	9/7/10	Sputum	Exacerbation (treatment with antibiotics)	70		6611	18.1	2.14	Y	Y	N	N	Y	heterozygous	F508del	Other	3																																																						
SRS6976606.SRR12184226	ECOCF0032, visit 6			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0032	Female	11/16/10	Sputum	Baseline			4445	12.2							homozygous	F508del	F508del	6																																																						
SRS6976608.SRR12184224	ECOCF0032, visit 7			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0032	Female	6/24/11	Sputum	Baseline	83		4665	12.8	2.16						homozygous	F508del	F508del	7																																																						
SRS6976614.SRR12184218	ECOCF0032, visit 8			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0032	Female	12/5/11	Oral swab	Baseline	91		4829	13.2	2.47	N	N	N	N	Y	homozygous	F508del	F508del	8																																																						
SRS6976616.SRR12184216	ECOCF0033, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0033	Female	3/10/10	Oral swab	Exacerbation (no treatment)			2175	6		N	N	N	N	Y	heterozygous	F508del	1585-8G>A	1																																																						
SRS6976617.SRR12184215	ECOCF0033, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0033	Female	4/23/10	Oral swab	Recovery (within 1 month after stopping antibiotics for exacerbation)			2219	6.1		N	N	N	N	Y	heterozygous	F508del	1585-8G>A	2																																																						
SRS6976619.SRR12184213	ECOCF0033, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0033	Female	5/5/10	Oral swab	Baseline	79		2231	6.1	0.76	N	N	N	N	Y	heterozygous	F508del	1585-8G>A	3																																																						
SRS6976620.SRR12184212	ECOCF0033, visit 4			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0033	Female	7/27/10	Oral swab	Exacerbation (treatment with antibiotics)			2314	6.3		N	N	N	N	Y	heterozygous	F508del	1585-8G>A	4																																																						
SRS6976621.SRR12184211	ECOCF0033, visit 5			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0033	Female	12/13/10	Oral swab	Exacerbation (no treatment)			2453	6.7		Y	Y	N	N	Y	heterozygous	F508del	1585-8G>A	5																																																						
SRS6976615.SRR12184217	ECOCF0033, visit 6			V4	Human	GAZ:United States of America	Human	Lung	Bronchial tree and alveoli		ECOCF0033	Female	1/18/11	Bronchoalveolar lavage (BAL)	Exacerbation (no treatment)			2489	6.8		Y	N	N	N	Y	heterozygous	F508del	1585-8G>A	6																																																						
SRS6977310.SRR12184700	ECOCF0004, visit 4			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0004	Female	1/11/11	Oral swab	Exacerbation (no treatment)	79		6737	18.4	2.41	Y	Y	N	N	Y	heterozygous	F508del	Other	4																																																						
SRS6976622.SRR12184210	ECOCF0033, visit 7			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0033	Female	11/28/11	Oral swab	Baseline	92		2803	7.7	1.12	Y	N	N	N	Y	heterozygous	F508del	1585-8G>A	7																																																						
SRS6976623.SRR12184209	ECOCF0033, visit 8			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0033	Female	4/2/12	Oral swab	Baseline	97		2929	8	1.3	Y	N	N	N	Y	heterozygous	F508del	1585-8G>A	8																																																						
SRS6976625.SRR12184207	ECOCF0035, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0035	Female	3/10/10	Oral swab	Baseline	70		6716	18.4	2.39	Y	Y	N	N	Y	homozygous	F508del	F508del	1																																																						
SRS6976626.SRR12184206	ECOCF0035, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0035	Female	6/15/10	Oral swab	Exacerbation (treatment with antibiotics)	52		6813	18.7	1.77	Y	Y	N	N	Y	homozygous	F508del	F508del	2																																																						
SRS6976624.SRR12184208	ECOCF0035, visit 3			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0035	Female	8/17/10	Sputum	Baseline			6876	18.8		Y	Y	N	N	Y	homozygous	F508del	F508del	3																																																						
SRS6976627.SRR12184205	ECOCF0035, visit 4			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0035	Female	12/14/10	Oral swab	Exacerbation (treatment with antibiotics)	62		6995	19.2	2.14	Y	Y	N	N	Y	homozygous	F508del	F508del	4																																																						
SRS6976628.SRR12184204	ECOCF0035, visit 5			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0035	Female	2/8/11	Oral swab	Exacerbation (no treatment)	70		7051	19.3	2.43	Y	Y	N	N	Y	homozygous	F508del	F508del	5																																																						
SRS6976630.SRR12184202	ECOCF0036, visit 1			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0036	Male	3/15/10	Sputum	Baseline	84		6755	18.5	3.11	N	Y	N	N	Y	heterozygous	F508del	W1282X	1																																																						
SRS6977311.SRR12184699	ECOCF0004, visit 5			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0004	Female	2/8/11	Oral swab	Exacerbation (treatment with antibiotics)	76		6765	18.5	2.34	Y	Y	N	N	Y	heterozygous	F508del	Other	5																																																						
SRS6976631.SRR12184201	ECOCF0036, visit 2			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0036	Male	5/26/10	Sputum	Baseline	65		6827	18.7	2.73	N	N	N	Y	Y	heterozygous	F508del	W1282X	2																																																						
SRS6976633.SRR12184200	ECOCF0036, visit 3			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0036	Male	8/13/10	Sputum	Exacerbation (treatment with antibiotics)			6906	18.9		Y	Y	N	Y	Y	heterozygous	F508del	W1282X	3																																																						
SRS6976632.SRR12184199	ECOCF0036, visit 4			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0036	Male	1/4/11	Sputum	Exacerbation (treatment with antibiotics)	68		7050	19.3	2.92	Y	Y	N	Y	Y	heterozygous	F508del	W1282X	4																																																						
SRS6976634.SRR12184198	ECOCF0036, visit 5			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0036	Male	1/12/11	Sputum	Recovery (within 1 month after stopping antibiotics for exacerbation)	57		7058	19.3	2.57	N	Y	N	Y	Y	heterozygous	F508del	W1282X	5																																																						
SRS6976635.SRR12184197	ECOCF0037, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0037	Male	3/15/10	Oral swab	Exacerbation (no treatment)	93		2849	7.8	1.31	Y	N	N	N	Y	homozygous	F508del	F508del	1																																																						
SRS6976636.SRR12184196	ECOCF0037, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0037	Male	8/5/10	Oral swab	Exacerbation (no treatment)	85		2992	8.2	1.2	Y	N	N	N	Y	homozygous	F508del	F508del	2																																																						
SRS6976637.SRR12184195	ECOCF0037, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0037	Male	8/9/10	Oral swab				2996	8.2							homozygous	F508del	F508del	3																																																						
SRS6977293.SRR12184717	ECOCF0001, visit 2			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0001	Female	3/29/10	Sputum	Exacerbation (no treatment)	22		6337	17.3	0.77	Y	Y	N	N	Y				2																																																						
SRS6977313.SRR12184697	ECOCF0005, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0005	Male	2/23/10	Oral swab	Baseline	72		4655	12.7	2.07	Y	Y	N	N	Y	homozygous	F508del	F508del	1																																																						
SRS6976638.SRR12184194	ECOCF0037, visit 4			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0037	Male	12/29/11	Oral swab	Exacerbation (no treatment)	72		3503	9.6	1.22	Y	Y	N	N	Y	homozygous	F508del	F508del	4																																																						
SRS6976639.SRR12184193	ECOCF0038, visit 1			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0038	Male	8/31/10	Sputum	Exacerbation (no treatment)			6957	19		Y	Y	N	Y	Y	heterozygous	F508del	H609R	1																																																						
SRS6976641.SRR12184191	ECOCF0038, visit 2			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0038	Male	2/8/11	Sputum	Baseline	51		7118	19.5	2.35	Y	N	N	Y	Y	heterozygous	F508del	H609R	2																																																						
SRS6976644.SRR12184188	ECOCF0039, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0039	Male	11/12/10	Oral swab	Exacerbation (no treatment)			2106	5.8		N	Y	N	N	Y	homozygous	F508del	F508del	1																																																						
SRS6976643.SRR12184189	ECOCF0039, visit 2			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0039	Male	1/9/11	Sputum	Exacerbation (treatment with antibiotics)	57		2164	5.9	0.51	N	Y	N	N	Y	homozygous	F508del	F508del	2																																																						
SRS6976642.SRR12184190	ECOCF0039, visit 4			V4	Human	GAZ:United States of America	Human				ECOCF0039	Male	6/20/11			60		2326	6.4	0.6	N	Y	N	N	Y	homozygous	F508del	F508del	4																																																						
SRS6976645.SRR12184187	ECOCF0039, visit 5			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0039	Male	11/14/11	Oral swab	Baseline			2473	6.8		N	Y	N	N	Y	homozygous	F508del	F508del	5																																																						
SRS6976646.SRR12184186	ECOCF0039, visit 7			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0039	Male	5/11/12	Oral swab	Exacerbation (no treatment)			2652	7.3		N	Y	N	N	Y	homozygous	F508del	F508del	7																																																						
SRS6977314.SRR12184696	ECOCF0005, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0005	Male	4/13/10	Oral swab	Exacerbation (no treatment)	57		4704	12.9	1.66	Y	Y	N	N	Y	homozygous	F508del	F508del	2																																																						
SRS6976647.SRR12184185	ECOCF0040, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0040	Female	3/18/10	Oral swab	Baseline			540	1.5		N	N	N	N	N	homozygous	F508del	F508del	1																																																						
SRS6976648.SRR12184184	ECOCF0040, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0040	Female	6/18/10	Oral swab	Baseline			632	1.7		N	N	N	N	N	homozygous	F508del	F508del	2																																																						
SRS6976649.SRR12184183	ECOCF0040, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0040	Female	9/7/10	Oral swab	Baseline			713	2		N	N	N	N	N	homozygous	F508del	F508del	3																																																						
SRS6976650.SRR12184182	ECOCF0040, visit 4			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0040	Female	2/15/11	Oral swab	Baseline			874	2.4		N	N	N	N	N	homozygous	F508del	F508del	4																																																						
SRS6976652.SRR12184180	ECOCF0040, visit 5			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0040	Female	3/16/12	Oral swab	Baseline			1269	3.5		N	N	N	N	N	homozygous	F508del	F508del	5																																																						
SRS6976653.SRR12184179	ECOCF0040, visit 6			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0040	Female	5/17/12	Oral swab				1331	3.6							homozygous	F508del	F508del	6																																																						
SRS6976655.SRR12184178	ECOCF0041, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0041	Female	3/18/10	Oral swab	Exacerbation (no treatment)	70		6866	18.8	2.05	N	N	N	N	Y	other	W1282X	W1282X	1																																																						
SRS6976654.SRR12184177	ECOCF0041, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0041	Female	4/22/10	Oral swab	Exacerbation (treatment with antibiotics)	73		6901	18.9	2.15	Y	Y	N	N	Y	other	W1282X	W1282X	2																																																						
SRS6976656.SRR12184176	ECOCF0041, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0041	Female	5/18/10	Oral swab	Exacerbation (no treatment)	73		6927	19	2.15	N	Y	N	N	Y	other	W1282X	W1282X	3																																																						
SRS6976657.SRR12184175	ECOCF0041, visit 4			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0041	Female	8/5/10	Oral swab	Baseline	80		7006	19.2	2.32	Y	Y	N	N	Y	other	W1282X	W1282X	4																																																						
SRS6976658.SRR12184174	ECOCF0041, visit 5			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0041	Female	11/22/11	Oral swab	Recovery (within 1 month after stopping antibiotics for exacerbation)	90		7480	20.5	2.74	N	N	N	N	Y	other	W1282X	W1282X	5																																																						
SRS6976660.SRR12184173	ECOCF0041, visit 6			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0041	Female	1/13/12	Oral swab	Exacerbation (no treatment)			7532	20.6		Y	N	N	N	Y	other	W1282X	W1282X	6																																																						
SRS6976659.SRR12184172	ECOCF0042, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0042	Female	3/23/10	Oral swab	Baseline			1189	3.3		N	Y	N	N	Y				1																																																						
SRS6976661.SRR12184171	ECOCF0042, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0042	Female	6/15/10	Oral swab	Exacerbation (no treatment)			1273	3.5		N	Y	N	N	Y				2																																																						
SRS6976663.SRR12184169	ECOCF0043, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0043	Male	3/26/10	Oral swab	Baseline			1106	3		N	N	N	N	N				1																																																						
SRS6976664.SRR12184168	ECOCF0043, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0043	Male	6/28/10	Oral swab	Baseline			1200	3.3		N	N	N	N	Y				2																																																						
SRS6976665.SRR12184167	ECOCF0043, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0043	Male	10/8/10	Oral swab	Baseline			1302	3.6		N	N	N	N	N				3																																																						
SRS6976666.SRR12184166	ECOCF0043, visit 4			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0043	Male	7/1/11	Oral swab	Baseline			1568	4.3		N	N	N	N	N				4																																																						
SRS6976667.SRR12184165	ECOCF0043, visit 5			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0043	Male	11/17/11	Oral swab	Baseline			1707	4.7		N	N	N	N	N				5																																																						
SRS6976750.SRR12184416	ECOCF0005, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0005	Male	7/20/10	Oral swab	Baseline			4802	13.1		Y	Y	N	N	Y	homozygous	F508del	F508del	3																																																						
SRS6976669.SRR12184164	ECOCF0044, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0044	Female	3/30/10	Oral swab	Exacerbation (no treatment)	90		6936	19	2.82	N	Y	N	N	Y	heterozygous	F508del	N1303K	1																																																						
SRS6976668.SRR12184163	ECOCF0044, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0044	Female	1/5/12	Oral swab	Baseline	87		7582	20.8	2.86	Y	Y	N	N	Y	heterozygous	F508del	N1303K	2																																																						
SRS6976670.SRR12184162	ECOCF0045, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0045	Female	3/29/10	Oral swab	Baseline	86		7149	19.6	3.29	Y	Y	N	N	Y	heterozygous	F508del		1																																																						
SRS6976671.SRR12184161	ECOCF0045, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0045	Female	6/11/10	Oral swab	Baseline	80		7223	19.8	3.04	N	Y	N	N	Y	heterozygous	F508del		2																																																						
SRS6976672.SRR12184160	ECOCF0045, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0045	Female	8/19/11	Oral swab	Baseline	91		7657	21	3.47	Y	Y	N	N	Y	heterozygous	F508del		3																																																						
SRS6976676.SRR12184156	ECOCF0046, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0046	Male	3/24/10	Oral swab	Baseline			2349	6.4		N	N	N	N	Y	heterozygous	F508del	R117H	1																																																						
SRS6976675.SRR12184157	ECOCF0046, visit 2			V4	Human	GAZ:United States of America	Human				ECOCF0046	Male	6/21/10					2438	6.7							heterozygous	F508del	R117H	2																																																						
SRS6976677.SRR12184155	ECOCF0047, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0047	Male	3/30/10	Oral swab	Baseline	80		2409	6.6	1.35	N	N	N	N	Y	heterozygous	F508del	G542X	1																																																						
SRS6976678.SRR12184154	ECOCF0047, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0047	Male	8/31/10	Oral swab	Baseline	110		2563	7	1.86	N	N	N	N	Y	heterozygous	F508del	G542X	2																																																						
SRS6976751.SRR12184415	ECOCF0005, visit 4			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0005	Male	9/28/10	Oral swab	Exacerbation (no treatment)	70		4872	13.3	2.12	Y	Y	N	N	Y	homozygous	F508del	F508del	4																																																						
SRS6976679.SRR12184153	ECOCF0047, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0047	Male	1/25/11	Oral swab	Baseline	111		2710	7.4	1.82	N	N	N	N	Y	heterozygous	F508del	G542X	3																																																						
SRS6976681.SRR12184152	ECOCF0047, visit 4			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0047	Male	6/22/11	Oral swab	Baseline	101		2858	7.8	1.81	N	N	N	N	Y	heterozygous	F508del	G542X	4																																																						
SRS6976680.SRR12184151	ECOCF0048, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0048	Female	8/17/10	Oral swab	Baseline	104		6561	18	3.68	Y	N	N	N	Y	homozygous	F508del	F508del	1																																																						
SRS6976682.SRR12184150	ECOCF0048, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0048	Female	12/21/10	Oral swab	Baseline	101		6687	18.3	3.63	Y	N	N	N	Y	homozygous	F508del	F508del	2																																																						
SRS6976683.SRR12184149	ECOCF0048, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0048	Female	6/22/11	Oral swab	Baseline			6870	18.8		Y	N	N	N	Y	homozygous	F508del	F508del	3																																																						
SRS6976684.SRR12184148	ECOCF0049, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0049	Female	3/30/10	Oral swab	Baseline	103		5452	14.9	3.37	Y	N	N	N	Y	heterozygous	F508del	7T9T variant	1																																																						
SRS6976686.SRR12184146	ECOCF0049, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0049	Female	8/31/10	Oral swab	Baseline	94		5606	15.3	3.12	N	N	N	N	Y	heterozygous	F508del	7T9T variant	2																																																						
SRS6976687.SRR12184145	ECOCF0049, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0049	Female	10/26/10	Oral swab	Baseline	108		5662	15.5	3.44	N	N	N	N	Y	heterozygous	F508del	7T9T variant	3																																																						
SRS6976752.SRR12184414	ECOCF0005, visit 5			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0005	Male	12/7/10	Oral swab	Exacerbation (no treatment)	69		4942	13.5	2.14	Y	Y	N	N	Y	homozygous	F508del	F508del	5																																																						
SRS6976688.SRR12184144	ECOCF0049, visit 4			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0049	Female	6/13/11	Oral swab	Baseline	100		5892	16.1	3.31	N	N	N	N	Y	heterozygous	F508del	7T9T variant	4																																																						
SRS6976690.SRR12184142	ECOCF0050, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0050	Male	3/30/10	Oral swab	Baseline	67		2210	6.1	0.31	N	N	N	N	N	heterozygous	F508del	A455E	1																																																						
SRS6976691.SRR12184141	ECOCF0050, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0050	Male	8/17/10	Oral swab	Baseline	118		2350	6.4	0.8	N	N	N	N	N	heterozygous	F508del	A455E	2																																																						
SRS6976692.SRR12184140	ECOCF0050, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0050	Male	1/25/11	Oral swab	Baseline	91		2511	6.9	0.74	N	N	N	N	N	heterozygous	F508del	A455E	3																																																						
SRS6976689.SRR12184143	ECOCF0050, visit 4			V4	Human	GAZ:United States of America	Human				ECOCF0050	Male	6/7/11		Baseline	92		2644	7.2	0.88	N	N	N	N	N	heterozygous	F508del	A455E	4																																																						
SRS6976693.SRR12184139	ECOCF0050, visit 5			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0050	Male	8/15/11	Oral swab	Baseline	98		2713	7.4	0.97	N	N	N	N	N	heterozygous	F508del	A455E	5																																																						
SRS6976695.SRR12184138	ECOCF0050, visit 6			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0050	Male	12/5/11	Oral swab	Baseline			2825	7.7		N	N	N	N	N	heterozygous	F508del	A455E	6																																																						
SRS6976694.SRR12184137	ECOCF0051, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0051	Male	3/30/10	Oral swab	Baseline			4589	12.6		Y	N	N	N	Y	other	R560T	N1303K	1																																																						
SRS6976698.SRR12184135	ECOCF0051, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0051	Male	6/22/10	Oral swab	On Antibiotics No Exacerbation			4673	12.8		Y	N	N	N	Y	other	R560T	N1303K	2																																																						
SRS6976697.SRR12184134	ECOCF0051, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0051	Male	9/21/10	Oral swab	On Antibiotics No Exacerbation			4764	13		Y	N	N	N	Y	other	R560T	N1303K	3																																																						
SRS6976699.SRR12184133	ECOCF0051, visit 4			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0051	Male	12/13/10	Oral swab	On Antibiotics No Exacerbation			4847	13.3		Y	Y	N	N	Y	other	R560T	N1303K	4																																																						
SRS6976701.SRR12184132	ECOCF0051, visit 5			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0051	Male	6/22/11	Oral swab	Exacerbation (no treatment)			5038	13.8		Y	N	N	N	Y	other	R560T	N1303K	5																																																						
SRS6976702.SRR12184130	ECOCF0052, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0052	Male	3/31/10	Oral swab	Baseline			6956	19		N	N	N	N	Y	heterozygous	F508del	R347H	1																																																						
SRS6976704.SRR12184129	ECOCF0052, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0052	Male	6/15/10	Oral swab	Baseline			7032	19.3		N	N	N	N	Y	heterozygous	F508del	R347H	2																																																						
SRS6976700.SRR12184131	ECOCF0052, visit 3			V4	Human	GAZ:United States of America	Human				ECOCF0052	Male	6/13/11		Baseline			7395	20.2		N	N	N	N	Y	heterozygous	F508del	R347H	3																																																						
SRS6976703.SRR12184128	ECOCF0053, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0053	Male	3/31/10	Oral swab	Baseline			529	1.4		N	N	N	N	Y	other	W1282X	L127dup	1																																																						
SRS6976706.SRR12184126	ECOCF0054, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0054	Female	3/31/10	Oral swab	Baseline			3565	9.8		N	N	N	N	N	heterozygous	F508del	R347H	1																																																						
SRS6976708.SRR12184124	ECOCF0054, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0054	Female	6/15/10	Oral swab	Baseline	82		3641	10	1.85	N	N	N	N	N	heterozygous	F508del	R347H	2																																																						
SRS6976709.SRR12184123	ECOCF0054, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0054	Female	9/7/10	Oral swab	Baseline	99		3725	10.2	2.05	N	N	N	N	N	heterozygous	F508del	R347H	3																																																						
SRS6976705.SRR12184127	ECOCF0054, visit 4			V4	Human	GAZ:United States of America	Human				ECOCF0054	Female	6/13/11		Baseline			4004	11		N	N	N	N	N	heterozygous	F508del	R347H	4																																																						
SRS6976710.SRR12184122	ECOCF0054, visit 5			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0054	Female	9/26/11	Oral swab	Baseline			4109	11.2		N	N	N	N	N	heterozygous	F508del	R347H	5																																																						
SRS6976711.SRR12184121	ECOCF0054, visit 6			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0054	Female	12/20/11	Oral swab	Baseline			4194	11.5		N	N	N	N	N	heterozygous	F508del	R347H	6																																																						
SRS6976712.SRR12184120	ECOCF0055, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0055	Female	3/31/10	Oral swab	Baseline			2112	5.8		N	N	N	N	N	heterozygous	F508del	R347H	1																																																						
SRS6976713.SRR12184119	ECOCF0055, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0055	Female	9/7/10	Oral swab	Baseline	115		2272	6.2	1.48	N	N	N	N	N	heterozygous	F508del	R347H	2																																																						
SRS6976714.SRR12184118	ECOCF0055, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0055	Female	6/13/11	Oral swab	Baseline			2551	7		N	N	N	N	N	heterozygous	F508del	R347H	3																																																						
SRS6976715.SRR12184117	ECOCF0055, visit 4			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0055	Female	9/26/11	Oral swab	Baseline			2656	7.3		N	N	N	N	N	heterozygous	F508del	R347H	4																																																						
SRS6976716.SRR12184116	ECOCF0055, visit 5			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0055	Female	12/20/11	Oral swab	Baseline			2741	7.5		N	N	N	N	N	heterozygous	F508del	R347H	5																																																						
SRS6976717.SRR12184115	ECOCF0056, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0056	Male	3/31/10	Oral swab	Baseline			5435	14.9		N	N	N	N	Y				1																																																						
SRS6976753.SRR12184413	ECOCF0005, visit 6			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0005	Male	9/20/11	Oral swab	Exacerbation (no treatment)			5229	14.3		Y	Y	N	N	Y	homozygous	F508del	F508del	6																																																						
SRS6976719.SRR12184113	ECOCF0056, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0056	Male	7/16/10	Oral swab	Baseline	88		5542	15.2	3.87	N	N	N	N	Y				2																																																						
SRS6976720.SRR12184112	ECOCF0056, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0056	Male	10/12/10	Oral swab	Baseline	103		5630	15.4	4.15	N	N	N	N	Y				3																																																						
SRS6976721.SRR12184111	ECOCF0056, visit 4			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0056	Male	6/22/11	Oral swab	Baseline	89		5883	16.1	4.03	N	N	N	N	Y				4																																																						
SRS6976724.SRR12184108	ECOCF0057, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0057	Female	4/9/10	Oral swab	Exacerbation (treatment with antibiotics)	92		6260	17.1	2.67	Y	N	N	Y	Y	heterozygous	F508del	R553X	1																																																						
SRS6976722.SRR12184110	ECOCF0057, visit 2			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0057	Female	8/17/10	Sputum	Exacerbation (no treatment)	84		6390	17.5	2.53	Y	N	N	Y	Y	heterozygous	F508del	R553X	2																																																						
SRS6976723.SRR12184109	ECOCF0057, visit 3			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0057	Female	2/15/11	Sputum	Baseline	82		6572	18	2.46	Y	N	N	Y	Y	heterozygous	F508del	R553X	3																																																						
SRS6976755.SRR12184411	ECOCF0006, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0006	Female	2/23/10	Oral swab	Baseline	78		4259	11.7	1.92	Y	Y	N	N	Y	heterozygous	F508del	I507del	1																																																						
SRS6976726.SRR12184107	ECOCF0058, visit 1			V4	Human	GAZ:United States of America	Human	Lung	Bronchial tree and alveoli		ECOCF0058	Female	4/6/10	Bronchoalveolar lavage (BAL)	Exacerbation (no treatment)	59		3368	9.2	1.05	Y	Y	Y	N	Y	heterozygous	F508del		1																																																						
SRS6976725.SRR12184106	ECOCF0058, visit 2			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0058	Female	4/9/10	Sputum	Exacerbation (treatment with antibiotics)			3371	9.2		Y	Y	Y	N	Y	heterozygous	F508del		2																																																						
SRS6976727.SRR12184105	ECOCF0058, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0058	Female	4/21/10	Oral swab	Exacerbation (treatment with antibiotics)	82		3383	9.3	1.47	Y	Y	Y	N	Y	heterozygous	F508del		3																																																						
SRS6976728.SRR12184104	ECOCF0058, visit 4			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0058	Female	7/16/10	Oral swab	Baseline			3469	9.5		Y	Y	Y	N	Y	heterozygous	F508del		4																																																						
SRS6976730.SRR12184102	ECOCF0059, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0059	Female	4/6/10	Oral swab	Exacerbation (no treatment)			251	0.7		N	N	N	N	N	homozygous	F508del	F508del	1																																																						
SRS6976731.SRR12184101	ECOCF0059, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0059	Female	9/28/10	Oral swab	Recovery (within 1 month after stopping antibiotics for exacerbation)			426	1.2		N	N	N	N	N	homozygous	F508del	F508del	2																																																						
SRS6976732.SRR12184100	ECOCF0059, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0059	Female	1/25/11	Oral swab	Baseline			545	1.5		N	N	N	N	N	homozygous	F508del	F508del	3																																																						
SRS6976733.SRR12184099	ECOCF0059, visit 4			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0059	Female	12/15/11	Oral swab	Baseline			869	2.4		N	N	N	N	N	homozygous	F508del	F508del	4																																																						
SRS6976734.SRR12184098	ECOCF0059, visit 5			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0059	Female	6/12/12	Oral swab	Baseline			1049	2.9		N	N	N	N	N	homozygous	F508del	F508del	5																																																						
SRS6977294.SRR12184716	ECOCF0001, visit 3			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0001	Female	4/5/10	Sputum	Recovery (within 1 month after stopping antibiotics for exacerbation)	55		6344	17.4	1.91	Y	Y	N	N	Y				3																																																						
SRS6976756.SRR12184410	ECOCF0006, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0006	Female	6/15/10	Oral swab	Exacerbation (no treatment)	74		4371	12	1.9	Y	N	N	N	Y	heterozygous	F508del	I507del	2																																																						
SRS6976735.SRR12184097	ECOCF0060, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0060	Female	8/10/10	Oral swab	Baseline	84		4900	13.4	2.35	Y	N	N	Y	Y	heterozygous	F508del	M470V	1																																																						
SRS6976736.SRR12184096	ECOCF0060, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0060	Female	9/14/10	Oral swab	Baseline	71		4935	13.5	2.07	Y	N	N	N	Y	heterozygous	F508del	M470V	2																																																						
SRS6976737.SRR12184095	ECOCF0060, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0060	Female	11/23/10	Oral swab	Exacerbation (no treatment)	71		5005	13.7	1.95	Y	N	N	N	Y	heterozygous	F508del	M470V	3																																																						
SRS6976739.SRR12184094	ECOCF0060, visit 4			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0060	Female	1/4/11	Oral swab	Exacerbation (no treatment)	77		5047	13.8	2.1	Y	Y	N	N	Y	heterozygous	F508del	M470V	4																																																						
SRS6976738.SRR12184093	ECOCF0061, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0061	Male	4/7/10	Oral swab	Exacerbation (no treatment)	84		5855	16	3.03	Y	N	N	N	Y	heterozygous	F508del		1																																																						
SRS6976741.SRR12184091	ECOCF0061, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0061	Male	8/10/10	Oral swab	Baseline	96		5980	16.4	3.45	Y	Y	N	N	Y	heterozygous	F508del		2																																																						
SRS6976757.SRR12184409	ECOCF0006, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0006	Female	8/3/10	Oral swab	Exacerbation (treatment with antibiotics)	70		4420	12.1	1.82	Y	N	N	N	Y	heterozygous	F508del	I507del	3																																																						
SRS6976742.SRR12184090	ECOCF0061, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0061	Male	1/4/11	Oral swab	Baseline	94		6127	16.8	3.69	Y	Y	N	N	Y	heterozygous	F508del		3																																																						
SRS6976823.SRR12184678	ECOCF0062, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0062	Female	4/8/10	Oral swab	Baseline	52		2642	7.2	0.79	Y	Y	Y	N	Y	heterozygous	F508del	R553X	1																																																						
SRS6976824.SRR12184677	ECOCF0062, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0062	Female	6/21/10	Oral swab				2716	7.4							heterozygous	F508del	R553X	2																																																						
SRS6976822.SRR12184676	ECOCF0062, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0062	Female	8/5/10	Oral swab	Exacerbation (treatment with antibiotics)	33		2761	7.6	0.53	Y	Y	Y	N	Y	heterozygous	F508del	R553X	3																																																						
SRS6976826.SRR12184675	ECOCF0062, visit 4			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0062	Female	2/10/12	Oral swab	Baseline	49		3315	9.1	0.89	Y	Y	Y	N	Y	heterozygous	F508del	R553X	4																																																						
SRS6976828.SRR12184672	ECOCF0063, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0063	Female	4/9/10	Oral swab	Baseline			1586	4.3		N	N	N	N	Y	other	p.5466x	p.Q1042x	1																																																						
SRS6976829.SRR12184671	ECOCF0063, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0063	Female	10/8/10	Oral swab	Baseline			1768	4.8		N	N	N	N	Y	other	p.5466x	p.Q1042x	2																																																						
SRS6976831.SRR12184669	ECOCF0063, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0063	Female	1/14/11	Oral swab	Baseline			1866	5.1		N	N	N	N	Y	other	p.5466x	p.Q1042x	3																																																						
SRS6976825.SRR12184674	ECOCF0063, visit 4			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0063	Female	1/10/12	Sputum	Baseline			2227	6.1		N	N	N	N	Y	other	p.5466x	p.Q1042x	4																																																						
SRS6976827.SRR12184673	ECOCF0063, visit 5			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0063	Female	3/15/12	Sputum	Baseline			2292	6.3		N	N	N	N	Y	other	p.5466x	p.Q1042x	5																																																						
SRS6976759.SRR12184408	ECOCF0006, visit 4			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0006	Female	9/14/10	Oral swab	Baseline	68		4462	12.2	1.84	Y	Y	N	N	Y	heterozygous	F508del	I507del	4																																																						
SRS6976832.SRR12184668	ECOCF0064, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0064	Female	4/9/10	Oral swab	Baseline			93	0.3		N	N	N	N	N	heterozygous	F508del	R74W	1																																																						
SRS6976833.SRR12184667	ECOCF0064, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0064	Female	5/6/10	Oral swab	Baseline			120	0.3		N	N	N	N	N	heterozygous	F508del	R74W	2																																																						
SRS6976834.SRR12184666	ECOCF0064, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0064	Female	10/22/10	Oral swab	Baseline			289	0.8		N	N	N	N	N	heterozygous	F508del	R74W	3																																																						
SRS6976836.SRR12184665	ECOCF0064, visit 4			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0064	Female	4/13/12	Oral swab	Baseline			828	2.3		N	N	N	N	N	heterozygous	F508del	R74W	4																																																						
SRS6976837.SRR12184663	ECOCF0065, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0065	Female	4/9/10	Oral swab	Exacerbation (treatment with antibiotics)			970	2.7		N	N	N	N	N	heterozygous	F508del		1																																																						
SRS6976840.SRR12184662	ECOCF0065, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0065	Female	4/29/10	Oral swab	Exacerbation (treatment with antibiotics)			990	2.7		N	Y	N	N	N	heterozygous	F508del		2																																																						
SRS6976838.SRR12184660	ECOCF0065, visit 4			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0065	Female	8/20/10	Oral swab	Baseline			1103	3		N	Y	N	N	N	heterozygous	F508del		4																																																						
SRS6976835.SRR12184664	ECOCF0065, visit 5			V4	Human	GAZ:United States of America	Human				ECOCF0065	Female	4/8/11		Baseline			1334	3.7		N	Y	N	N	Y	heterozygous	F508del		5																																																						
SRS6976842.SRR12184658	ECOCF0066, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0066	Male	4/9/10	Oral swab	Baseline			2725	7.5		N	Y	N	N	Y	homozygous	F508del	F508del	1																																																						
SRS6976843.SRR12184657	ECOCF0066, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0066	Male	8/13/10	Oral swab	Exacerbation (treatment with antibiotics)			2851	7.8	1.59	N	Y	N	N	N	homozygous	F508del	F508del	2																																																						
SRS6976758.SRR12184407	ECOCF0006, visit 5			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0006	Female	10/26/10	Oral swab	Baseline	83		4504	12.3	2.11	Y	Y	N	N	Y	heterozygous	F508del	I507del	5																																																						
SRS6976844.SRR12184656	ECOCF0066, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0066	Male	10/29/10	Oral swab	Exacerbation (treatment with antibiotics)	113		2928	8	2.02	N	Y	N	N	N	homozygous	F508del	F508del	3																																																						
SRS6976845.SRR12184655	ECOCF0066, visit 4			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0066	Male	10/28/11	Oral swab	Baseline	101		3292	9	2.03	Y	Y	N	N	Y	homozygous	F508del	F508del	4																																																						
SRS6976846.SRR12184654	ECOCF0066, visit 5			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0066	Male	2/3/12	Oral swab	Baseline	92		3390	9.3	1.97	Y	Y	N	N	Y	homozygous	F508del	F508del	5																																																						
SRS6976847.SRR12184653	ECOCF0066, visit 6			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0066	Male	3/23/12	Oral swab	Baseline	87		3439	9.4	1.87	Y	N	N	N	Y	homozygous	F508del	F508del	6																																																						
SRS6976848.SRR12184652	ECOCF0067, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0067	Female	4/13/10	Oral swab	Recovery (within 1 month after stopping antibiotics for exacerbation)			374	1		N	Y	N	N	N	heterozygous	I507del	F508del	1																																																						
SRS6976849.SRR12184651	ECOCF0067, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0067	Female	2/18/11	Oral swab	Baseline			685	1.9		N	Y	N	N	Y	heterozygous	I507del	F508del	2																																																						
SRS6976850.SRR12184650	ECOCF0067, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0067	Female	6/6/11	Oral swab	Exacerbation (no treatment)			793	2.2		N	Y	N	N	Y	heterozygous	I507del	F508del	3																																																						
SRS6976852.SRR12184649	ECOCF0067, visit 4			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0067	Female	1/12/12	Oral swab	Exacerbation (no treatment)			1013	2.8		Y	Y	N	N	Y	heterozygous	I507del	F508del	4																																																						
SRS6976853.SRR12184647	ECOCF0067, visit 5			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0067	Female	1/17/12	Oral swab	Exacerbation (no treatment)			1018	2.8		Y	Y	N	N	Y	heterozygous	I507del	F508del	5																																																						
SRS6976854.SRR12184646	ECOCF0068, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0068	Male	4/13/10	Oral swab	Baseline	100		2328	6.4	1.13	Y	N	N	N	Y	heterozygous	F508del	1161delC	1																																																						
SRS6976855.SRR12184645	ECOCF0068, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0068	Male	7/20/10	Oral swab	Baseline	105		2426	6.6	1.31	Y	N	N	N	Y	heterozygous	F508del	1161delC	2																																																						
SRS6976856.SRR12184644	ECOCF0069, visit 1			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0069	Female	6/22/10	Sputum	Exacerbation (no treatment)	48		7431	20.3	1.34	Y	N	N	N	Y	heterozygous	F508del	G542X	1																																																						
SRS6976857.SRR12184643	ECOCF0069, visit 2			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0069	Female	8/24/10	Sputum	Baseline	71		7494	20.5	2.03	Y	N	N	N	Y	heterozygous	F508del	G542X	2																																																						
SRS6976858.SRR12184642	ECOCF0070, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0070	Female	4/13/10	Oral swab	Exacerbation (no treatment)			1810	5		N	N	N	N	Y	homozygous	F508del	F508del	1																																																						
SRS6976883.SRR12184617	ECOCF0070, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0070	Female	5/25/10	Oral swab	Exacerbation (no treatment)	118		1852	5.1	1.06	N	N	N	N	Y	homozygous	F508del	F508del	2																																																						
SRS6976885.SRR12184616	ECOCF0070, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0070	Female	8/18/10	Oral swab	Baseline			1937	5.3		Y	Y	N	N	Y	homozygous	F508del	F508del	3																																																						
SRS6976884.SRR12184615	ECOCF0070, visit 4			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0070	Female	12/3/10	Oral swab	Baseline			2044	5.6		Y	Y	N	N	Y	homozygous	F508del	F508del	4																																																						
SRS6976889.SRR12184611	ECOCF0071, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0071	Male	4/13/10	Oral swab	Baseline	89		3067	8.4	1.71	N	N	N	N	Y	other	R560T	1717-1G->A	1																																																						
SRS6976760.SRR12184406	ECOCF0006, visit 6			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0006	Female	4/5/11	Oral swab	Baseline	87		4665	12.8	2.32	Y	N	N	N	Y	heterozygous	F508del	I507del	6																																																						
SRS6976890.SRR12184610	ECOCF0071, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0071	Male	6/7/10	Oral swab	Baseline	81		3122	8.5	1.55	N	N	N	N	Y	other	R560T	1717-1G->A	2																																																						
SRS6976893.SRR12184609	ECOCF0071, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0071	Male	6/29/10	Oral swab	Recovery (within 1 month after stopping antibiotics for exacerbation)	120		3144	8.6	2.3	N	N	N	N	Y	other	R560T	1717-1G->A	3																																																						
SRS6976886.SRR12184614	ECOCF0071, visit 4			V4	Human	GAZ:United States of America	Human				ECOCF0071	Male	7/12/10					3157	8.6							other	R560T	1717-1G->A	4																																																						
SRS6976891.SRR12184608	ECOCF0071, visit 5			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0071	Male	10/12/10	Oral swab	Baseline	132		3249	8.9	2.35	N	N	N	N	Y	other	R560T	1717-1G->A	5																																																						
SRS6976892.SRR12184607	ECOCF0071, visit 6			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0071	Male	7/12/11	Oral swab	Recovery (within 1 month after stopping antibiotics for exacerbation)	111		3522	9.6	2.18	N	N	N	N	Y	other	R560T	1717-1G->A	6																																																						
SRS6976895.SRR12184605	ECOCF0072, visit 1			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0072	Male	4/16/10	Sputum	Baseline	35		2002	5.5	0.43	N	Y	N	N	Y	homozygous	F508del	F508del	1																																																						
SRS6976896.SRR12184606	ECOCF0072, visit 2			V4	Human	GAZ:United States of America	Human				ECOCF0072	Male	6/21/10					2068	5.7							homozygous	F508del	F508del	2																																																						
SRS6976902.SRR12184598	ECOCF0072, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0072	Male	8/13/10	Oral swab	Exacerbation (treatment with antibiotics)	34		2121	5.8	0.42	N	Y	N	N	N	homozygous	F508del	F508del	3																																																						
SRS6976903.SRR12184597	ECOCF0072, visit 4			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0072	Male	10/15/10	Oral swab	Exacerbation (no treatment)	36		2184	6	0.48	N	Y	N	N	N	homozygous	F508del	F508del	4																																																						
SRS6976894.SRR12184604	ECOCF0072, visit 5			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0072	Male	2/18/11	Sputum	Recovery (within 1 month after stopping antibiotics for exacerbation)	32		2310	6.3	0.42	N	Y	N	N	Y	homozygous	F508del	F508del	5																																																						
SRS6976761.SRR12184405	ECOCF0006, visit 7			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0006	Female	9/1/11	Oral swab	Baseline	93		4814	13.2	2.54	Y	N	N	N	Y	heterozygous	F508del	I507del	7																																																						
SRS6976897.SRR12184603	ECOCF0072, visit 6			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0072	Male	11/11/11	Sputum	Exacerbation (no treatment)			2576	7.1		N	Y	N	N	Y	homozygous	F508del	F508del	6																																																						
SRS6976904.SRR12184596	ECOCF0072, visit 7			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0072	Male	1/6/12	Oral swab	Baseline	34		2632	7.2	0.42	N	Y	N	N	Y	homozygous	F508del	F508del	7																																																						
SRS6976898.SRR12184602	ECOCF0072, visit 8			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0072	Male	4/13/12	Sputum	Exacerbation (no treatment)	43		2730	7.5	0.55	N	Y	N	N	Y	homozygous	F508del	F508del	8																																																						
SRS6976901.SRR12184600	ECOCF0072, visit 9			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0072	Male	5/16/12	Sputum	Exacerbation (no treatment)			2763	7.6							homozygous	F508del	F508del	9																																																						
SRS6976900.SRR12184599	ECOCF0072, visit 10			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0072	Male	8/16/12	Sputum				2855	7.8							homozygous	F508del	F508del	10																																																						
SRS6976905.SRR12184595	ECOCF0073, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0073	Female	4/20/10	Oral swab	Baseline			4788	13.1		N	N	N	N	N				1																																																						
SRS6976906.SRR12184594	ECOCF0073, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0073	Female	7/6/10	Oral swab	Baseline			4865	13.3		N	N	N	N	N				2																																																						
SRS6976931.SRR12184569	ECOCF0074, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0074	Female	4/20/10	Oral swab	Baseline			528	1.4		N	N	N	N	N	homozygous	F508del	F508del	1																																																						
SRS6976932.SRR12184568	ECOCF0074, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0074	Female	8/10/10	Oral swab	Baseline			640	1.8		N	N	N	N	N	homozygous	F508del	F508del	2																																																						
SRS6976762.SRR12184404	ECOCF0006, visit 8			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0006	Female	12/15/11	Oral swab	Baseline	84		4919	13.5	2.37	Y	N	N	N	Y	heterozygous	F508del	I507del	8																																																						
SRS6976933.SRR12184567	ECOCF0074, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0074	Female	11/30/10	Oral swab	Baseline			752	2.1		N	N	N	N	N	homozygous	F508del	F508del	3																																																						
SRS6976935.SRR12184565	ECOCF0074, visit 4			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0074	Female	9/16/11	Oral swab	Baseline			1042	2.9		N	N	N	N	N	homozygous	F508del	F508del	4																																																						
SRS6976936.SRR12184564	ECOCF0075, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0075	Female	4/21/10	Oral swab	Baseline			1112	3		N	N	N	N	N	homozygous	F508del	F508del	1																																																						
SRS6976937.SRR12184563	ECOCF0075, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0075	Female	1/11/11	Oral swab	Baseline			1377	3.8		N	N	N	N	N	homozygous	F508del	F508del	2																																																						
SRS6976941.SRR12184559	ECOCF0076, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0076	Female	4/21/10	Oral swab	Baseline	49		5095	13.9	1.46	N	Y	N	N	Y	other	3849+10kbC->T	W1282X	1																																																						
SRS6976942.SRR12184558	ECOCF0076, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0076	Female	5/7/10	Oral swab	Exacerbation (no treatment)	41		5111	14	1.21	N	Y	N	N	Y	other	3849+10kbC->T	W1282X	2																																																						
SRS6976939.SRR12184562	ECOCF0076, visit 3			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0076	Female	9/14/10	Sputum	Baseline	64		5241	14.3	1.83	N	Y	N	Y	Y	other	3849+10kbC->T	W1282X	3																																																						
SRS6976938.SRR12184561	ECOCF0076, visit 4			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0076	Female	12/7/10	Sputum	Exacerbation (no treatment)	55		5325	14.6	1.59	Y	N	N	Y	Y	other	3849+10kbC->T	W1282X	4																																																						
SRS6976940.SRR12184560	ECOCF0076, visit 5			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0076	Female	2/15/11	Sputum	Exacerbation (treatment with antibiotics)	55		5395	14.8	1.59	N	N	N	Y	Y	other	3849+10kbC->T	W1282X	5																																																						
SRS6976763.SRR12184403	ECOCF0006, visit 9			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0006	Female	5/7/12	Oral swab	Exacerbation (treatment with antibiotics)	64		5063	13.9	1.83	Y	N	N	N	Y	heterozygous	F508del	I507del	9																																																						
SRS6976943.SRR12184557	ECOCF0076, visit 6			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0076	Female	12/16/11	Oral swab	Exacerbation (treatment with antibiotics)	64		5699	15.6	1.94	N	N	N	Y	Y	other	3849+10kbC->T	W1282X	6																																																						
SRS6976944.SRR12184556	ECOCF0076, visit 7			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0076	Female	2/1/12	Oral swab	Exacerbation (treatment with antibiotics)	56		5746	15.7	1.7	N	N	N	Y	Y	other	3849+10kbC->T	W1282X	7																																																						
SRS6976945.SRR12184554	ECOCF0077, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0077	Male	4/21/10	Oral swab	Baseline	125		2249	6.2	1.94	N	N	N	N	N	heterozygous	F508del	D1152H	1																																																						
SRS6976947.SRR12184553	ECOCF0077, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0077	Male	10/12/10	Oral swab	Baseline	131		2423	6.6	1.9	N	N	N	N	N	heterozygous	F508del	D1152H	2																																																						
SRS6976948.SRR12184552	ECOCF0077, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0077	Male	4/5/11	Oral swab	Baseline	118		2598	7.1	1.9	N	N	N	N	N	heterozygous	F508del	D1152H	3																																																						
SRS6976949.SRR12184551	ECOCF0077, visit 4			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0077	Male	11/22/11	Oral swab	Exacerbation (no treatment)	124		2829	7.7	2.08	N	N	N	N	N	heterozygous	F508del	D1152H	4																																																						
SRS6976950.SRR12184550	ECOCF0078, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0078	Male	4/23/10	Oral swab	Baseline	110		6137	16.8	3.61	N	N	N	N	Y	homozygous	F508del	F508del	1																																																						
SRS6976951.SRR12184549	ECOCF0078, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0078	Male	8/27/10	Oral swab	Baseline	105		6263	17.1	3.44	N	N	N	N	Y	homozygous	F508del	F508del	2																																																						
SRS6976764.SRR12184402	ECOCF0006, visit 10			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0006	Female	6/11/12	Oral swab	Recovery (within 1 month after stopping antibiotics for exacerbation)	78		5098	14	2.22	Y	N	N	N	Y	heterozygous	F508del	I507del	10																																																						
SRS6976952.SRR12184548	ECOCF0078, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0078	Male	9/14/10	Oral swab	Baseline	109		6281	17.2	3.66	N	N	N	N	Y	homozygous	F508del	F508del	3																																																						
SRS6976953.SRR12184547	ECOCF0079, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0079	Male	4/27/10	Oral swab	Baseline			444	1.2		N	N	N	N	N	heterozygous	F508del	Q359K/T360K	1																																																						
SRS6976954.SRR12184546	ECOCF0079, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0079	Male	8/10/10	Oral swab	Baseline			549	1.5		N	N	N	N	N	heterozygous	F508del	Q359K/T360K	2																																																						
SRS6977004.SRR12184497	ECOCF0079, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0079	Male	10/26/10	Oral swab	Baseline			626	1.7		N	N	N	N	N	heterozygous	F508del	Q359K/T360K	3																																																						
SRS6977008.SRR12184495	ECOCF0080, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0080	Female	4/27/10	Oral swab	Baseline			858	2.3		N	N	N	N	N	heterozygous	F508del	D1152H	1																																																						
SRS6977005.SRR12184494	ECOCF0080, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0080	Female	12/7/10	Oral swab	Baseline			1082	3		N	N	N	N	N	heterozygous	F508del	D1152H	2																																																						
SRS6977007.SRR12184493	ECOCF0081, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0081	Male	4/27/10	Oral swab	Baseline			3303	9		N	N	N	N	Y	homozygous	F508del	F508del	1																																																						
SRS6977006.SRR12184492	ECOCF0081, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0081	Male	9/7/10	Oral swab	Baseline	111		3436	9.4	1.85	N	N	N	N	Y	homozygous	F508del	F508del	2																																																						
SRS6976766.SRR12184400	ECOCF0007, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0007	Female	2/23/10	Oral swab	Baseline	67		2747	7.5	0.92	N	N	N	N	N	other	R709X	Other	1																																																						
SRS6977009.SRR12184491	ECOCF0081, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0081	Male	7/5/11	Oral swab	Baseline	106		3737	10.2	1.98	Y	Y	N	N	Y	homozygous	F508del	F508del	3																																																						
SRS6977010.SRR12184490	ECOCF0081, visit 4			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0081	Male	10/20/11	Oral swab	Baseline			3844	10.5		Y	N	N	N	Y	homozygous	F508del	F508del	4																																																						
SRS6977012.SRR12184489	ECOCF0081, visit 5			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0081	Male	1/17/12	Oral swab	Baseline	103		3933	10.8	2.04	Y	N	N	N	Y	homozygous	F508del	F508del	5																																																						
SRS6977011.SRR12184488	ECOCF0082, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0082	Female	4/27/10	Oral swab	Baseline			173	0.5		N	N	N	N	N				1																																																						
SRS6977013.SRR12184487	ECOCF0082, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0082	Female	7/20/10	Oral swab	Baseline			257	0.7		N	N	N	N	N				2																																																						
SRS6977015.SRR12184486	ECOCF0083, visit 1			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0083	Male	4/28/10	Sputum	Baseline			4773	13.1		N	N	N	N	N	homozygous	F508del	F508del	1																																																						
SRS6977014.SRR12184483	ECOCF0083, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0083	Male	6/15/10	Oral swab	Exacerbation (treatment with antibiotics)	62		4821	13.2	1.67	Y	N	N	N	Y	homozygous	F508del	F508del	2																																																						
SRS6977016.SRR12184484	ECOCF0083, visit 3			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0083	Male	10/3/11	Sputum	Exacerbation (treatment with antibiotics)	50		5296	14.5	1.59	N	N	N	N	Y	homozygous	F508del	F508del	3																																																						
SRS6977017.SRR12184482	ECOCF0083, visit 4			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0083	Male	5/21/12	Oral swab	Exacerbation (treatment with antibiotics)	53		5527	15.1	1.79	N	N	N	N	Y	homozygous	F508del	F508del	4																																																						
SRS6977020.SRR12184481	ECOCF0085, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0085	Male	5/3/10	Oral swab	Baseline	104		5705	15.6	3.97	Y	Y	N	N	Y	homozygous	F508del	F508del	1																																																						
SRS6977019.SRR12184480	ECOCF0085, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0085	Male	8/17/10	Oral swab	Baseline	115		5811	15.9	4.38	Y	Y	N	N	Y	homozygous	F508del	F508del	2																																																						
SRS6977021.SRR12184479	ECOCF0085, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0085	Male	12/14/10	Oral swab	Baseline	118		5930	16.2	4.81	Y	Y	N	N	Y	homozygous	F508del	F508del	3																																																						
SRS6977022.SRR12184478	ECOCF0086, visit 1			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0086	Male	5/3/10	Sputum	Recovery (within 1 month after stopping antibiotics for exacerbation)	62		3975	10.9	1.56	N	Y	N	N	Y	heterozygous	F508del	Q493X	1																																																						
SRS6977023.SRR12184477	ECOCF0086, visit 2			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0086	Male	8/24/10	Sputum	Baseline	77		4088	11.2	1.99	N	Y	N	N	Y	heterozygous	F508del	Q493X	2																																																						
SRS6977024.SRR12184476	ECOCF0086, visit 3			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0086	Male	11/12/10	Sputum	Exacerbation (no treatment)	78		4168	11.4	1.94	N	Y	N	N	Y	heterozygous	F508del	Q493X	3																																																						
SRS6977025.SRR12184475	ECOCF0086, visit 4			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0086	Male	5/16/12	Sputum	Exacerbation (no treatment)	84		4719	12.9	2.38	N	Y	N	N	Y	heterozygous	F508del	Q493X	4																																																						
SRS6977051.SRR12184449	ECOCF0087, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0087	Male	5/4/10	Oral swab	Baseline			3691	10.1		Y	Y	N	N	Y	heterozygous	F508del	G551D	1																																																						
SRS6977052.SRR12184448	ECOCF0087, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0087	Male	7/20/10	Oral swab	Baseline			3768	10.3		Y	Y	N	N	Y	heterozygous	F508del	G551D	2																																																						
SRS6977053.SRR12184447	ECOCF0088, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0088	Male	5/4/10	Oral swab	On Antibiotics No Exacerbation			2857	7.8		N	N	N	N	Y	other	1717-1G->A	5T	1																																																						
SRS6976767.SRR12184399	ECOCF0007, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0007	Female	10/19/10	Oral swab	Baseline	72		2985	8.2	1.22	N	N	N	N	N	other	R709X	Other	2																																																						
SRS6977054.SRR12184446	ECOCF0088, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0088	Male	10/26/10	Oral swab	Baseline			3032	8.3		N	N	N	N	Y	other	1717-1G->A	5T	2																																																						
SRS6977056.SRR12184445	ECOCF0088, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0088	Male	3/13/12	Oral swab	Exacerbation (no treatment)	88		3536	9.7	1.49	N	N	N	N	Y	other	1717-1G->A	5T	3																																																						
SRS6977055.SRR12184444	ECOCF0090, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0090	Male	5/5/10	Oral swab	Baseline	110		2937	8	1.62	N	N	N	N	N	heterozygous	F508del		1																																																						
SRS6977057.SRR12184443	ECOCF0090, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0090	Male	11/9/10	Oral swab	Baseline	112		3125	8.6	1.62	N	N	N	N	N	heterozygous	F508del		2																																																						
SRS6977059.SRR12184441	ECOCF0091, visit 1			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0091	Male	5/7/10	Sputum	Baseline	58		4868	13.3	1.64	N	N	N	N	Y	homozygous	F508del	F508del	1																																																						
SRS6977060.SRR12184440	ECOCF0091, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0091	Male	12/9/11	Oral swab	Baseline	71		5449	14.9	2.52	Y	Y	N	N	Y	homozygous	F508del	F508del	2																																																						
SRS6977062.SRR12184438	ECOCF0091, visit 4			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0091	Male	3/9/12	Oral swab	Baseline	68		5540	15.2	2.46	Y	N	N	N	Y	homozygous	F508del	F508del	4																																																						
SRS6977063.SRR12184437	ECOCF0091, visit 5			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0091	Male	5/16/12	Oral swab	Exacerbation (treatment with antibiotics)	56		5608	15.4	2.09	N	Y	N	N	Y	homozygous	F508del	F508del	5																																																						
SRS6976768.SRR12184398	ECOCF0007, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0007	Female	4/5/11	Oral swab	Baseline	76		3153	8.6	1.23	N	N	N	N	N	other	R709X	Other	3																																																						
SRS6977064.SRR12184436	ECOCF0093, visit 1			V4	Human	GAZ:United States of America	Human	Lung	Bronchial tree and alveoli		ECOCF0093	Female	5/17/10	Bronchoalveolar lavage (BAL)	Exacerbation (no treatment)			934	2.6		N	N	N	N	Y	heterozygous	F508del	Other	1																																																						
SRS6977065.SRR12184435	ECOCF0093, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0093	Female	6/8/10	Oral swab	Recovery (within 1 month after stopping antibiotics for exacerbation)			956	2.6		N	N	N	N	Y	heterozygous	F508del	Other	2																																																						
SRS6977066.SRR12184434	ECOCF0093, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0093	Female	9/21/10	Oral swab	Baseline			1061	2.9		N	N	N	N	Y	heterozygous	F508del	Other	3																																																						
SRS6977067.SRR12184433	ECOCF0093, visit 4			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0093	Female	12/19/11	Oral swab	Baseline			1515	4.1		Y	Y	N	N	Y	heterozygous	F508del	Other	4																																																						
SRS6977068.SRR12184432	ECOCF0094, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0094	Male	5/18/10	Oral swab	Baseline	84		2110	5.8	1.33	N	N	N	N	N	heterozygous	F508del		1																																																						
SRS6977069.SRR12184431	ECOCF0094, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0094	Male	9/14/10	Oral swab		75		2229	6.1	1.27						heterozygous	F508del		2																																																						
SRS6977070.SRR12184430	ECOCF0095, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0095	Female	5/18/10	Oral swab	Exacerbation (treatment with antibiotics)	85		3611	9.9	1.59	Y	N	N	N	Y	homozygous	F508del	F508del	1																																																						
SRS6977071.SRR12184429	ECOCF0095, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0095	Female	7/8/10	Oral swab	Exacerbation (no treatment)	85		3662	10	1.62	Y	N	N	N	Y	homozygous	F508del	F508del	2																																																						
SRS6977073.SRR12184427	ECOCF0095, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0095	Female	12/14/10	Oral swab	Exacerbation (no treatment)	77		3821	10.5	1.46	Y	Y	N	N	Y	homozygous	F508del	F508del	3																																																						
SRS6976770.SRR12184397	ECOCF0008, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0008	Male	2/23/10	Oral swab	Baseline	107		1888	5.2	1.03	N	N	N	N	N	other	S912L	W1282X	1																																																						
SRS6977098.SRR12184911	ECOCF0096, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0096	Male	5/20/10	Oral swab	Baseline	70		5518	15.1	2.39	Y	Y	N	N	Y	heterozygous	F508del	R560T	1																																																						
SRS6977074.SRR12184426	ECOCF0096, visit 2			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0096	Male	1/4/11	Sputum	Exacerbation (no treatment)	55		5747	15.7	1.99	Y	Y	N	N	Y	heterozygous	F508del	R560T	2																																																						
SRS6977100.SRR12184910	ECOCF0096, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0096	Male	10/21/11	Oral swab	Exacerbation (treatment with antibiotics)			6037	16.5		Y	Y	N	N	Y	heterozygous	F508del	R560T	3																																																						
SRS6977101.SRR12184909	ECOCF0096, visit 4			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0096	Male	2/14/12	Oral swab	Baseline	67		6153	16.8	2.55	Y	Y	N	Y	Y	heterozygous	F508del	R560T	4																																																						
SRS6977102.SRR12184908	ECOCF0097, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0097	Male	5/21/10	Oral swab	Exacerbation (no treatment)			356	1		N	N	N	N	N	other	2184IrsA+	G1244E	1																																																						
SRS6977104.SRR12184907	ECOCF0097, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0097	Male	7/13/10	Oral swab	Baseline			409	1.1		N	Y	N	N	N	other	2184IrsA+	G1244E	2																																																						
SRS6977103.SRR12184906	ECOCF0097, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0097	Male	8/19/10	Oral swab	Exacerbation (treatment with antibiotics)			446	1.2		N	Y	N	N	N	other	2184IrsA+	G1244E	3																																																						
SRS6977106.SRR12184905	ECOCF0097, visit 4			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0097	Male	8/17/11	Oral swab	Baseline			809	2.2		N	Y	N	N	N	other	2184IrsA+	G1244E	4																																																						
SRS6977105.SRR12184904	ECOCF0097, visit 5			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0097	Male	12/14/11	Oral swab	Baseline			928	2.5		N	Y	N	N	Y	other	2184IrsA+	G1244E	5																																																						
SRS6976769.SRR12184396	ECOCF0008, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0008	Male	5/25/10	Oral swab	Baseline	101		1979	5.4	1.09	N	N	N	N	N	other	S912L	W1282X	2																																																						
SRS6977108.SRR12184902	ECOCF0097, visit 6			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0097	Male	4/19/12	Oral swab	Baseline			1055	2.9		N	Y	N	N	Y	other	2184IrsA+	G1244E	6																																																						
SRS6977110.SRR12184901	ECOCF0098, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0098	Female	5/21/10	Oral swab	Baseline	78		4938	13.5	2.29	N	N	N	N	Y				1																																																						
SRS6977109.SRR12184900	ECOCF0098, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0098	Female	11/3/10	Oral swab	Baseline	95		5104	14	2.49	N	N	N	N	Y				2																																																						
SRS6977112.SRR12184899	ECOCF0098, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0098	Female	12/2/10	Oral swab	Baseline	100		5133	14.1	2.68	N	N	N	N	Y				3																																																						
SRS6977111.SRR12184898	ECOCF0098, visit 4			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0098	Female	8/16/11	Oral swab	Baseline	88		5390	14.8	2.6	N	N	N	N	Y				4																																																						
SRS6977113.SRR12184897	ECOCF0098, visit 5			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0098	Female	11/23/11	Oral swab	Baseline	91		5489	15	2.73	N	N	N	N	Y				5																																																						
SRS6976839.SRR12184661	ECOCF0065, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0065	Female	5/21/10	Oral swab	Baseline			1012	2.8		N	Y	N	N	N	heterozygous	F508del		3																																																						
SRS6977115.SRR12184896	ECOCF0100, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0100	Male	5/25/10	Oral swab	Baseline	111		2435	6.7	1.38	N	N	N	N	N	other	G542X	S1235R	1																																																						
SRS6977114.SRR12184895	ECOCF0100, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0100	Male	8/17/10	Oral swab	Baseline	117		2519	6.9	1.45	N	N	N	N	N	other	G542X	S1235R	2																																																						
SRS6977116.SRR12184894	ECOCF0100, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0100	Male	11/9/10	Oral swab	Baseline	120		2603	7.1	1.38	N	N	N	N	N	other	G542X	S1235R	3																																																						
SRS6976771.SRR12184395	ECOCF0008, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0008	Male	8/10/10	Oral swab	Baseline	89		2056	5.6		N	N	N	N	N	other	S912L	W1282X	3																																																						
SRS6977118.SRR12184893	ECOCF0100, visit 4			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0100	Male	2/9/11	Oral swab	Baseline	119		2695	7.4	1.45	N	N	N	N	N	other	G542X	S1235R	4																																																						
SRS6977120.SRR12184890	ECOCF0100, visit 5			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0100	Male	12/13/11	Oral swab	Baseline			3002	8.2		N	N	N	N	Y	other	G542X	S1235R	5																																																						
SRS6977121.SRR12184889	ECOCF0101, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0101	Female	5/25/10	Oral swab	Baseline			8255	22.6		Y	N	N	N	Y	heterozygous	W1282X	F508del	1																																																						
SRS6977123.SRR12184888	ECOCF0102, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0102	Male	6/14/11	Oral swab	Baseline	84		5073	13.9	2.4	Y	Y	N	N	Y	other	W1282X	G542X	1																																																						
SRS6977122.SRR12184887	ECOCF0103, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0103	Female	6/1/10	Oral swab	Exacerbation (no treatment)			1185	3.2		N	N	N	N	Y	heterozygous	F508del	unknown	1																																																						
SRS6977124.SRR12184886	ECOCF0104, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0104	Male	6/8/10	Oral swab	Baseline			346	0.9		N	N	N	N	N	heterozygous	F508del	Other	1																																																						
SRS6977125.SRR12184885	ECOCF0104, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0104	Male	9/21/10	Oral swab	Baseline			451	1.2		N	N	N	N	N	heterozygous	F508del	Other	2																																																						
SRS6976772.SRR12184394	ECOCF0008, visit 4			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0008	Male	11/30/10	Oral swab	Baseline	111		2168	5.9	1.25	N	N	N	N	N	other	S912L	W1282X	4																																																						
SRS6977126.SRR12184884	ECOCF0104, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0104	Male	12/19/11	Oral swab	Baseline			905	2.5		N	N	N	N	Y	heterozygous	F508del	Other	3																																																						
SRS6977128.SRR12184882	ECOCF0105, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0105	Male	9/21/10	Oral swab	Baseline			451	1.2		N	N	N	N	N	heterozygous	F508del	Other	1																																																						
SRS6977129.SRR12184881	ECOCF0105, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0105	Male	6/8/11	Oral swab	Baseline			711	1.9		N	N	N	N	Y	heterozygous	F508del	Other	2																																																						
SRS6977131.SRR12184879	ECOCF0105, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0105	Male	12/19/11	Oral swab	Exacerbation (no treatment)			905	2.5		N	N	N	N	Y	heterozygous	F508del	Other	3																																																						
SRS6977127.SRR12184883	ECOCF0105, visit 4			V4	Human	GAZ:United States of America	Human	Lung	Bronchial tree and alveoli		ECOCF0105	Male	2/15/12	Bronchoalveolar lavage (BAL)	Exacerbation (no treatment)			963	2.6		N	N	N	N	Y	heterozygous	F508del	Other	4																																																						
SRS6977132.SRR12184878	ECOCF0106, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0106	Male	6/4/10	Oral swab	Baseline	80		3515	9.6	1.51	N	N	N	N	Y	homozygous	F508del	F508del	1																																																						
SRS6977133.SRR12184877	ECOCF0106, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0106	Male	9/23/10	Oral swab	Baseline			3626	9.9		N	N	N	N	Y	homozygous	F508del	F508del	2																																																						
SRS6977134.SRR12184876	ECOCF0107, visit 1			V4	Human	GAZ:United States of America	Human	Lung	Bronchial tree and alveoli		ECOCF0107	Female	6/8/10	Bronchoalveolar lavage (BAL)	Exacerbation (treatment with antibiotics)			18	0		N	N	N	N	N				1																																																						
SRS6977138.SRR12184873	ECOCF0108, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0108	Female	6/15/10	Oral swab	Exacerbation (no treatment)			4439	12.2		N	Y	N	N	Y	heterozygous	F508del	A559T	1																																																						
SRS6977135.SRR12184875	ECOCF0108, visit 2			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0108	Female	11/19/10	Sputum	Exacerbation (no treatment)			4596	12.6		N	Y	N	N	Y	heterozygous	F508del	A559T	2																																																						
SRS6977137.SRR12184872	ECOCF0108, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0108	Female	7/21/11	Oral swab	Baseline	59		4840	13.3	1.51	N	N	N	N	Y	heterozygous	F508del	A559T	3																																																						
SRS6977136.SRR12184874	ECOCF0108, visit 4			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0108	Female	9/22/11	Sputum	Exacerbation (no treatment)	45		4903	13.4	1.2	N	N	N	N	Y	heterozygous	F508del	A559T	4																																																						
SRS6977139.SRR12184871	ECOCF0108, visit 5			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0108	Female	1/27/12	Oral swab	Baseline	52		5030	13.8	1.39	N	N	N	N	Y	heterozygous	F508del	A559T	5																																																						
SRS6977140.SRR12184870	ECOCF0109, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0109	Male	6/16/10	Oral swab	Baseline	83		5078	13.9	2.53	N	Y	N	N	Y	heterozygous	F508del	W1282X	1																																																						
SRS6977141.SRR12184868	ECOCF0109, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0109	Male	9/23/10	Oral swab	Baseline			5177	14.2		N	Y	N	N	Y	heterozygous	F508del	W1282X	2																																																						
SRS6977144.SRR12184867	ECOCF0109, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0109	Male	11/16/10	Oral swab	Baseline			5231	14.3		N	Y	N	N	Y	heterozygous	F508del	W1282X	3																																																						
SRS6977145.SRR12184866	ECOCF0109, visit 4			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0109	Male	1/25/11	Oral swab	Baseline	81		5301	14.5	2.72	N	Y	N	N	Y	heterozygous	F508del	W1282X	4																																																						
SRS6976798.SRR12184368	ECOCF0009, visit 5			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0009	Male	2/25/10	Oral swab	Baseline	58				1.35	Y	N	N	N	Y	heterozygous	F508del		5																																																						
SRS6977143.SRR12184865	ECOCF0109, visit 5			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0109	Male	11/11/11	Oral swab	Baseline	78		5591	15.3	2.88	N	Y	N	N	Y	heterozygous	F508del	W1282X	5																																																						
SRS6977146.SRR12184864	ECOCF0110, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0110	Female	6/22/10	Oral swab	Baseline			896	2.5		N	N	N	N	N	heterozygous	F508del	Other	1																																																						
SRS6977171.SRR12184839	ECOCF0110, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0110	Female	12/20/11	Oral swab	Baseline			1442	3.9		N	N	N	N	N	heterozygous	F508del	Other	2																																																						
SRS6977173.SRR12184838	ECOCF0110, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0110	Female	3/20/12	Oral swab	Baseline			1533	4.2		N	N	N	N	N	heterozygous	F508del	Other	3																																																						
SRS6977172.SRR12184837	ECOCF0111, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0111	Male	9/23/10	Oral swab	Exacerbation (treatment with antibiotics)	98		6485	17.8	3.68	N	N	N	N	Y	heterozygous	F508del	G542X	1																																																						
SRS6977174.SRR12184836	ECOCF0111, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0111	Male	12/14/10	Oral swab	Baseline	95		6567	18	3.94	N	N	N	N	Y	heterozygous	F508del	G542X	2																																																						
SRS6977175.SRR12184835	ECOCF0111, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0111	Male	2/11/11	Oral swab	Baseline	92		6626	18.1	3.93	N	N	N	N	Y	heterozygous	F508del	G542X	3																																																						
SRS6977177.SRR12184833	ECOCF0112, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0112	Female	6/23/10	Oral swab	Baseline	75		4111	11.3	1.69	N	N	N	N	Y	heterozygous	F508del	3120+1G->A	1																																																						
SRS6977295.SRR12184715	ECOCF0001, visit 4			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0001	Female	7/6/10	Sputum	Exacerbation (treatment with antibiotics)			6436	17.6		Y	Y	N	N	Y				4																																																						
SRS6976799.SRR12184367	ECOCF0009, visit 6			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0009	Male	3/29/10	Oral swab	Baseline						N	N	N	N	Y	heterozygous	F508del		6																																																						
SRS6977178.SRR12184832	ECOCF0112, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0112	Female	12/21/10	Oral swab	Baseline			4292	11.8		N	N	N	N	Y	heterozygous	F508del	3120+1G->A	2																																																						
SRS6977179.SRR12184831	ECOCF0113, visit 1			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0113	Female	6/25/10	Sputum	Baseline	68		7706	21.1	2.3	Y	Y	N	N	N	heterozygous	F508del	R560T	1																																																						
SRS6977180.SRR12184830	ECOCF0114, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0114	Male	6/25/10	Oral swab	Baseline			153	0.4		N	N	N	N	N	other	p.R553x	unknown	1																																																						
SRS6977181.SRR12184829	ECOCF0115, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0115	Female	7/7/10	Oral swab	Baseline	97		3891	10.7	2.07	Y	Y	N	N	Y	homozygous	F508del	F508del	1																																																						
SRS6977183.SRR12184828	ECOCF0115, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0115	Female	10/12/10	Oral swab	Baseline	80		3988	10.9	1.71	Y	Y	N	N	Y	homozygous	F508del	F508del	2																																																						
SRS6977182.SRR12184827	ECOCF0115, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0115	Female	12/7/10	Oral swab	Baseline	105		4044	11.1	2.15	Y	Y	N	N	Y	homozygous	F508del	F508del	3																																																						
SRS6977184.SRR12184826	ECOCF0115, visit 4			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0115	Female	7/12/11	Oral swab	Baseline			4261	11.7		Y	Y	N	N	Y	homozygous	F508del	F508del	4																																																						
SRS6977185.SRR12184825	ECOCF0115, visit 5			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0115	Female	12/6/11	Oral swab	Baseline	95		4408	12.1	2.16	Y	Y	N	N	Y	homozygous	F508del	F508del	5																																																						
SRS6977186.SRR12184824	ECOCF0115, visit 6			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0115	Female	3/19/12	Oral swab	Baseline	96		4512	12.4	2.16	Y	Y	N	N	Y	homozygous	F508del	F508del	6																																																						
SRS6977188.SRR12184822	ECOCF0116, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0116	Female	7/9/10	Oral swab	Baseline			4545	12.4		Y	Y	N	N	Y	other	W1282X	W1282X	1																																																						
SRS6976801.SRR12184365	ECOCF0009, visit 7			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0009	Male	6/11/10	Oral swab	Exacerbation (no treatment)	59				1.36	Y	N	N	N	Y	heterozygous	F508del		7																																																						
SRS6977190.SRR12184821	ECOCF0116, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0116	Female	7/6/11	Oral swab	Baseline			4907	13.4		Y	Y	N	N	Y	other	W1282X	W1282X	2																																																						
SRS6977189.SRR12184820	ECOCF0116, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0116	Female	10/12/11	Oral swab				5005	13.7		Y	Y	N	N	Y	other	W1282X	W1282X	3																																																						
SRS6977191.SRR12184819	ECOCF0117, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0117	Female	7/9/10	Oral swab	Baseline			51	0.1		N	N	N	N	N	heterozygous	F508del	W1282X	1																																																						
SRS6977192.SRR12184818	ECOCF0117, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0117	Female	10/5/11	Oral swab	Baseline			504	1.4		N	N	N	N	Y	heterozygous	F508del	W1282X	2																																																						
SRS6977193.SRR12184817	ECOCF0117, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0117	Female	2/6/12	Oral swab	Baseline			628	1.7		N	N	N	N	Y	heterozygous	F508del	W1282X	3																																																						
SRS6977194.SRR12184816	ECOCF0117, visit 4			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0117	Female	5/17/12	Oral swab	Baseline			729	2		N	N	N	N	Y	heterozygous	F508del	W1282X	4																																																						
SRS6977243.SRR12184767	ECOCF0118, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0118	Female	7/22/10	Oral swab	Exacerbation (no treatment)	59		7176	19.6	1.85	N	Y	N	N	Y	homozygous	F508del	F508del	1																																																						
SRS6977244.SRR12184766	ECOCF0119, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0119	Male	7/22/10	Oral swab	Baseline	104		3333	9.1	2.29	N	N	N	N	Y	heterozygous	F508del	4016insT	1																																																						
SRS6977245.SRR12184765	ECOCF0120, visit 1			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0120	Female	7/27/10	Sputum	Baseline			5372	14.7		Y	Y	N	N	Y	homozygous	F508del	F508del	1																																																						
SRS6977247.SRR12184763	ECOCF0121, visit 1			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0121	Male	4/30/10	Sputum	Exacerbation (treatment with antibiotics)	52		3183	8.7	1.02	Y	Y	Y	N	Y	heterozygous	F508del	3120+1G->A	1																																																						
SRS6977255.SRR12184755	ECOCF0121, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0121	Male	5/5/10	Oral swab				3188	8.7		Y	Y	Y	N	Y	heterozygous	F508del	3120+1G->A	2																																																						
SRS6977248.SRR12184762	ECOCF0121, visit 3			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0121	Male	10/8/10	Sputum	Recovery (within 1 month after stopping antibiotics for exacerbation)			3344	9.2		Y	Y	N	Y	Y	heterozygous	F508del	3120+1G->A	3																																																						
SRS6977249.SRR12184761	ECOCF0121, visit 4			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0121	Male	12/16/10	Sputum				3413	9.3		Y	Y	N	Y	Y	heterozygous	F508del	3120+1G->A	4																																																						
SRS6977250.SRR12184760	ECOCF0121, visit 5			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0121	Male	1/28/11	Sputum	Recovery (within 1 month after stopping antibiotics for exacerbation)			3456	9.5		Y	N	Y	N	Y	heterozygous	F508del	3120+1G->A	5																																																						
SRS6977251.SRR12184759	ECOCF0121, visit 6			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0121	Male	6/17/11	Sputum	Baseline	38		3596	9.8	0.77	Y	N	Y	N	Y	heterozygous	F508del	3120+1G->A	6																																																						
SRS6977252.SRR12184758	ECOCF0121, visit 7			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0121	Male	9/1/11	Sputum		34		3672	10.1	0.71	Y	N	Y	N	Y	heterozygous	F508del	3120+1G->A	7																																																						
SRS6977253.SRR12184757	ECOCF0121, visit 8			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0121	Male	12/23/11	Sputum	Baseline	43		3785	10.4	0.93	Y	N	Y	N	Y	heterozygous	F508del	3120+1G->A	8																																																						
SRS6977254.SRR12184756	ECOCF0121, visit 9			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0121	Male	5/4/12	Sputum	Recovery (within 1 month after stopping antibiotics for exacerbation)	44		3918	10.7	0.97	Y	N	Y	N	Y	heterozygous	F508del	3120+1G->A	9																																																						
SRS6976802.SRR12184364	ECOCF0009, visit 8			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0009	Male	8/30/10	Oral swab	Baseline						Y	N	N	N	Y	heterozygous	F508del		8																																																						
SRS6977257.SRR12184754	ECOCF0122, visit 1			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0122	Female	7/30/10	Sputum	Exacerbation (no treatment)	69		7058	19.3	2.09	N	Y	N	N	Y	heterozygous	F508del	N1303K	1																																																						
SRS6977258.SRR12184752	ECOCF0122, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0122	Female	7/8/11	Oral swab	Exacerbation (no treatment)	84		7401	20.3	2.73	Y	Y	N	N	Y	heterozygous	F508del	N1303K	2																																																						
SRS6977260.SRR12184751	ECOCF0122, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0122	Female	8/16/11	Oral swab	Exacerbation (no treatment)	51		7440	20.4	1.66	Y	Y	N	N	Y	heterozygous	F508del	N1303K	3																																																						
SRS6977259.SRR12184750	ECOCF0123, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0123	Male	7/30/10	Oral swab	Recovery (within 1 month after stopping antibiotics for exacerbation)			749	2.1		N	N	N	N	Y	other	Other		1																																																						
SRS6977261.SRR12184749	ECOCF0123, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0123	Male	10/1/10	Oral swab	Baseline			812	2.2		N	Y	N	N	Y	other	Other		2																																																						
SRS6977262.SRR12184748	ECOCF0123, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0123	Male	3/16/12	Oral swab	Baseline			1344	3.7		N	Y	N	N	Y	other	Other		3																																																						
SRS6977263.SRR12184747	ECOCF0124, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0124	Male	8/10/10	Oral swab	Baseline	101		3772	10.3	1.73	N	N	N	N	Y	homozygous	F508del	F508del	1																																																						
SRS6977264.SRR12184746	ECOCF0124, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0124	Male	10/22/10	Oral swab	Baseline	100		3845	10.5	1.75	N	N	N	N	Y	homozygous	F508del	F508del	2																																																						
SRS6977265.SRR12184745	ECOCF0125, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0125	Female	8/10/10	Oral swab	Baseline	90		2541	7	1.33	N	N	N	N	N	other	W1282X		1																																																						
SRS6977307.SRR12184703	ECOCF0004, visit 2			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0004	Female	8/17/10	Sputum	Exacerbation (treatment with antibiotics)	58		6590	18	1.77	Y	Y	N	N	Y	heterozygous	F508del	Other	2																																																						
SRS6977312.SRR12184698	ECOCF0004, visit 6			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0004	Female	6/6/11	Oral swab	Baseline			6883	18.8		Y	Y	N	N	Y	heterozygous	F508del	Other	6																																																						
SRS6977266.SRR12184744	ECOCF0127, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0127	Female	8/17/10	Oral swab	Baseline	79		8515	23.3	2.84	N	N	N	N	Y	other	3849+10kbC->T	3849+10kbC->T	1																																																						
SRS6977267.SRR12184743	ECOCF0128, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0128	Female	8/20/10	Oral swab	Exacerbation (no treatment)	52		4364	11.9	1.5	Y	Y	N	N	Y	other	I507del	A559T	1																																																						
SRS6977268.SRR12184741	ECOCF0128, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0128	Female	10/12/11	Oral swab	Recovery (within 1 month after stopping antibiotics for exacerbation)	76		4782	13.1	2.18	Y	Y	N	N	Y	other	I507del	A559T	2																																																						
SRS6977270.SRR12184740	ECOCF0128, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0128	Female	3/23/12	Oral swab	Baseline	61		4945	13.5	1.75	Y	Y	N	N	Y	other	I507del	A559T	3																																																						
SRS6977271.SRR12184739	ECOCF0129, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0129	Female	8/24/10	Oral swab	Baseline	102		8760	24	2.97	Y	N	N	N	Y	heterozygous	F508del	1898+1G->A	1																																																						
SRS6977330.SRR12184680	ECOCF0130, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0130	Female	8/31/10	Oral swab	Baseline			39	0.1		N	N	N	N	N		F508del	I502T	1																																																						
SRS6977272.SRR12184738	ECOCF0131, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0131	Female	9/9/10	Oral swab	Baseline			883	2.4		N	N	N	N	N	other	621+1G->T	Other	1																																																						
SRS6977273.SRR12184737	ECOCF0131, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0131	Female	12/2/11	Oral swab	Baseline			1332	3.6		N	N	N	N	N	other	621+1G->T	Other	2																																																						
SRS6977274.SRR12184736	ECOCF0131, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0131	Female	5/24/12	Oral swab	Exacerbation (treatment with antibiotics)			1506	4.1		N	N	N	N	N	other	621+1G->T	Other	3																																																						
SRS6976773.SRR12184393	ECOCF0009, visit 4			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0009	Male	11/29/10	Sputum	Exacerbation (treatment with antibiotics)						Y	N	N	N	Y	heterozygous	F508del		4																																																						
SRS6977275.SRR12184735	ECOCF0132, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0132	Male	9/14/10	Oral swab	Baseline			4573	12.5		N	N	N	N	N	heterozygous	F508del	R553X	1																																																						
SRS6977276.SRR12184734	ECOCF0133, visit 1			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0133	Male	9/20/10	Sputum	Baseline	79		4728	12.9	2.18	Y	Y	N	N	Y	homozygous	F508del	F508del	1																																																						
SRS6977277.SRR12184733	ECOCF0133, visit 2			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0133	Male	12/3/10	Sputum	Baseline	75		4802	13.1	2.12	Y	Y	N	N	Y	homozygous	F508del	F508del	2																																																						
SRS6977278.SRR12184732	ECOCF0133, visit 3			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0133	Male	2/4/11	Sputum	Exacerbation (no treatment)	66		4865	13.3	1.94	Y	Y	N	N	Y	homozygous	F508del	F508del	3																																																						
SRS6977280.SRR12184730	ECOCF0133, visit 4			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0133	Male	6/24/11	Sputum	Baseline	64		5005	13.7	1.94	Y	Y	N	N	Y	homozygous	F508del	F508del	4																																																						
SRS6977281.SRR12184729	ECOCF0133, visit 5			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0133	Male	12/16/11	Sputum	Baseline	79		5180	14.2	2.52	Y	Y	N	N	Y	homozygous	F508del	F508del	5																																																						
SRS6977282.SRR12184728	ECOCF0133, visit 6			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0133	Male	4/11/12	Oral swab	Exacerbation (treatment with antibiotics)	94		5297	14.5	3.13	Y	Y	N	N	Y	homozygous	F508del	F508del	6																																																						
SRS6977283.SRR12184727	ECOCF0134, visit 1			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0134	Male	9/20/10	Sputum	Baseline	94		5474	15	2.94	Y	Y	N	N	Y	homozygous	F508del	F508del	1																																																						
SRS6977284.SRR12184726	ECOCF0134, visit 2			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0134	Male	12/3/10	Sputum	Baseline	92		5548	15.2	3.2	Y	Y	N	N	Y	homozygous	F508del	F508del	2																																																						
SRS6977285.SRR12184725	ECOCF0134, visit 3			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0134	Male	6/24/11	Sputum	Exacerbation (no treatment)	78		5751	15.7	2.89	Y	Y	N	N	Y	homozygous	F508del	F508del	3																																																						
SRS6977287.SRR12184724	ECOCF0134, visit 4			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0134	Male	12/16/11	Sputum	Exacerbation (no treatment)	86		5926	16.2	3.31	Y	Y	N	N	Y	homozygous	F508del	F508del	4																																																						
SRS6977288.SRR12184722	ECOCF0134, visit 5			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0134	Male	3/1/12	Oral swab	Baseline	85		6002	16.4	3.27	Y	Y	N	N	Y	homozygous	F508del	F508del	5																																																						
SRS6977286.SRR12184723	ECOCF0134, visit 6			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0134	Male	3/30/12	Sputum	Exacerbation (no treatment)	68		6031	16.5	2.64	Y	Y	N	N	Y	homozygous	F508del	F508del	6																																																						
SRS6977289.SRR12184721	ECOCF0134, visit 7			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0134	Male	4/13/12	Oral swab	Exacerbation (treatment with antibiotics)	97		6045	16.6	3.83	Y	Y	N	N	Y	homozygous	F508del	F508del	7																																																						
SRS6977315.SRR12184695	ECOCF0135, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0135	Male	9/28/10	Oral swab	Exacerbation (no treatment)	63		6139	16.8	2.18	Y	Y	N	N	Y	homozygous	F508del	F508del	1																																																						
SRS6977316.SRR12184694	ECOCF0135, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0135	Male	9/16/11	Oral swab	Baseline	60		6492	17.8	2.54	Y	Y	N	N	Y	homozygous	F508del	F508del	2																																																						
SRS6977317.SRR12184693	ECOCF0135, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0135	Male	11/7/11	Oral swab	Exacerbation (no treatment)	56		6544	17.9	2.26	Y	Y	N	N	Y	homozygous	F508del	F508del	3																																																						
SRS6977318.SRR12184692	ECOCF0135, visit 4			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0135	Male	12/29/11	Oral swab	Baseline	61		6596	18.1	2.63	Y	Y	N	N	Y	homozygous	F508del	F508del	4																																																						
SRS6977319.SRR12184691	ECOCF0135, visit 5			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0135	Male	1/27/12	Oral swab	Baseline	61		6625	18.1	2.61	Y	Y	N	N	Y	homozygous	F508del	F508del	5																																																						
SRS6977320.SRR12184690	ECOCF0135, visit 6			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0135	Male	3/2/12	Oral swab	Baseline	63		6660	18.2	2.67	Y	Y	N	N	Y	homozygous	F508del	F508del	6																																																						
SRS6977321.SRR12184689	ECOCF0135, visit 7			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0135	Male	4/27/12	Oral swab	Exacerbation (no treatment)	51		6716	18.4	2.17	Y	Y	N	N	Y	homozygous	F508del	F508del	7																																																						
SRS6977322.SRR12184688	ECOCF0137, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0137	Male	9/30/10	Oral swab	Baseline	89		7026	19.2	4.13	N	N	N	N	N	homozygous	F508del	F508del	1																																																						
SRS6977323.SRR12184687	ECOCF0138, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0138	Male	10/14/10	Oral swab	Exacerbation (no treatment)	59		3970	10.9	1.13	Y	Y	N	Y	Y	homozygous	F508del	F508del	1																																																						
SRS6977324.SRR12184686	ECOCF0138, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0138	Male	2/2/12	Oral swab	Exacerbation (no treatment)	45		4446	12.2	0.94	Y	N	N	Y	Y	homozygous	F508del	F508del	2																																																						
SRS6976803.SRR12184363	ECOCF0009, visit 9			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0009	Male	8/19/11	Oral swab	Baseline	83				2.04	Y	Y	N	N	Y	heterozygous	F508del		9																																																						
SRS6977327.SRR12184683	ECOCF0140, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0140	Male	10/26/10	Oral swab	Baseline			3195	8.7		N	N	N	N	Y	heterozygous	F508del	W1282X	1																																																						
SRS6977328.SRR12184682	ECOCF0140, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0140	Male	10/3/11	Oral swab	Baseline	82		3537	9.7	1.55	N	N	N	N	Y	heterozygous	F508del	W1282X	2																																																						
SRS6977329.SRR12184681	ECOCF0140, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0140	Male	1/17/12	Oral swab	Baseline			3643	10		Y	N	N	N	Y	heterozygous	F508del	W1282X	3																																																						
SRS6977331.SRR12184679	ECOCF0130, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0130	Female	10/29/10	Oral swab	Baseline			98	0.3		N	N	N	N	N		F508del	I502T	2																																																						
SRS6976743.SRR12184423	ECOCF0130, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0130	Female	1/4/11	Oral swab	Baseline			165	0.5		N	N	N	N	Y		F508del	I502T	3																																																						
SRS6976744.SRR12184421	ECOCF0143, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0143	Female	11/16/10	Oral swab	Baseline			2137	5.9		N	N	N	N	N	other	4374+1G->T	Other	1																																																						
SRS6976745.SRR12184422	ECOCF0143, visit 2			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0143	Female	6/30/11	Sputum	Exacerbation (no treatment)			2363	6.5		N	N	N	N	N	other	4374+1G->T	Other	2																																																						
SRS6976746.SRR12184420	ECOCF0144, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0144	Female	11/16/10	Oral swab	Baseline			2819	7.7		N	N	N	N	N	other	1540A>G	1716+63ins11	1																																																						
SRS6976747.SRR12184419	ECOCF0144, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0144	Female	8/18/11	Oral swab	Baseline	91		3094	8.5	1.04	N	N	N	N	N	other	1540A>G	1716+63ins11	2																																																						
SRS6976804.SRR12184362	ECOCF0009, visit 10			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0009	Male	11/23/11	Oral swab	Exacerbation (no treatment)						Y	N	N	N	Y	heterozygous	F508del		10																																																						
SRS6976749.SRR12184417	ECOCF0144, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0144	Female	10/3/11	Oral swab		73		3140	8.6	0.91						other	1540A>G	1716+63ins11	3																																																						
SRS6976774.SRR12184392	ECOCF0144, visit 4			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0144	Female	3/1/12	Oral swab	Baseline	98		3290	9	1.2	N	N	N	N	N	other	1540A>G	1716+63ins11	4																																																						
SRS6976775.SRR12184391	ECOCF0145, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0145	Female	12/13/10	Oral swab	Baseline			5399	14.8		N	N	N	N	Y		unknown		1																																																						
SRS6976776.SRR12184390	ECOCF0146, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0146	Male	12/17/10	Oral swab	Baseline			1166	3.2		N	N	N	N	N	heterozygous	F508del	R117H	1																																																						
SRS6976777.SRR12184389	ECOCF0146, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0146	Male	7/12/11	Oral swab	Exacerbation (no treatment)			1373	3.8		Y	N	N	N	Y	heterozygous	F508del	R117H	2																																																						
SRS6976778.SRR12184388	ECOCF0147, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0147	Male	1/11/11	Oral swab	Exacerbation (no treatment)			7129	19.5		N	Y	N	N	Y	homozygous	F508del	F508del	1																																																						
SRS6976779.SRR12184387	ECOCF0149, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0149	Male	2/8/11	Oral swab	Baseline			161	0.4		N	N	N	N	N	heterozygous	M1V	F508del	1																																																						
SRS6976780.SRR12184386	ECOCF0149, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0149	Male	9/1/11	Oral swab	Baseline			366	1		N	N	N	N	N	heterozygous	M1V	F508del	2																																																						
SRS6976781.SRR12184385	ECOCF0149, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0149	Male	12/15/11	Oral swab	Baseline			471	1.3		N	N	N	N	N	heterozygous	M1V	F508del	3																																																						
SRS6977296.SRR12184714	ECOCF0001, visit 5			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0001	Female	8/3/10	Sputum	Recovery (within 1 month after stopping antibiotics for exacerbation)			6464	17.7		Y	Y	N	N	Y				5																																																						
SRS6976782.SRR12184384	ECOCF0150, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0150	Male	2/8/11	Oral swab	Baseline			1159	3.2		N	N	N	N	N	other	W1282x	5T Variant	1																																																						
SRS6976787.SRR12184380	ECOCF0151, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0151	Female	8/26/11	Oral swab	Exacerbation (no treatment)	41		3883	10.6		Y	N	N	Y	Y	other	3120+1G->A	3120+1G->A	2																																																						
SRS6976784.SRR12184382	ECOCF0151, visit 1			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0151	Female	8/26/11	Sputum	Exacerbation (no treatment)	41		3883	10.6		Y	N	N	Y	Y	other	3120+1G->A	3120+1G->A	1																																																						
SRS6976785.SRR12184379	ECOCF0151, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0151	Female	10/20/11	Oral swab	Exacerbation (no treatment)	49		3938	10.8	1.24	Y	N	N	Y	Y	other	3120+1G->A	3120+1G->A	3																																																						
SRS6976788.SRR12184378	ECOCF0151, visit 5			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0151	Female	3/30/12	Oral swab	Exacerbation (no treatment)	47		4100	11.2	1.25	Y	N	N	Y	Y	other	3120+1G->A	3120+1G->A	5																																																						
SRS6976786.SRR12184381	ECOCF0151, visit 4			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0151	Female	3/30/12	Sputum	Exacerbation (no treatment)	47		4100	11.2	1.25	Y	N	N	Y	Y	other	3120+1G->A	3120+1G->A	4																																																						
SRS6976790.SRR12184377	ECOCF0151, visit 6			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0151	Female	6/8/12	Oral swab	Exacerbation (no treatment)	48		4170	11.4	1.34	Y	N	N	Y	Y	other	3120+1G->A	3120+1G->A	6																																																						
SRS6976789.SRR12184376	ECOCF0152, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0152	Male	8/26/11	Oral swab	Baseline	74		5504	15.1	3.14	Y	Y	N	N	Y	other	3120+1G->A	3120+1G->A	1																																																						
SRS6976791.SRR12184375	ECOCF0152, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0152	Male	12/6/11	Oral swab	Baseline	67		5606	15.3	2.86	Y	Y	N	N	Y	other	3120+1G->A	3120+1G->A	2																																																						
SRS6976792.SRR12184374	ECOCF0152, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0152	Male	3/30/12	Oral swab	Exacerbation (no treatment)	47		5721	15.7	1.25	Y	Y	N	N	Y	other	3120+1G->A	3120+1G->A	3																																																						
SRS6976793.SRR12184373	ECOCF0153, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0153	Male	11/15/11	Oral swab	Exacerbation (treatment with antibiotics)			355	1		N	N	N	N	N	other	p.Gln98Arg	p.Gln98Arg	1																																																						
SRS6976794.SRR12184371	ECOCF0153, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0153	Male	6/6/12	Oral swab	Baseline			559	1.5		N	N	N	N	N	other	p.Gln98Arg	p.Gln98Arg	2																																																						
SRS6976796.SRR12184370	ECOCF0154, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0154	Male	12/8/11	Oral swab	Baseline			262	0.7		N	Y	N	N	N	homozygous	F508del	F508del	1																																																						
SRS6976797.SRR12184369	ECOCF0155, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0155	Female	12/2/11	Oral swab	Exacerbation (no treatment)			6216	17		N	Y	N	N	Y	other	R1158X	3849+10kbC>T	1																																																						
SRS6976536.SRR12184296	ECOCF0155, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0155	Female	12/29/11	Oral swab	Exacerbation (treatment with antibiotics)			6243	17.1		N	Y	N	N	Y	other	R1158X	3849+10kbC>T	2																																																						
SRS6976537.SRR12184295	ECOCF0155, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0155	Female	3/19/12	Oral swab	Exacerbation (no treatment)	59		6324	17.3	1.8	N	N	N	Y	Y	other	R1158X	3849+10kbC>T	3																																																						
SRS6976538.SRR12184294	ECOCF0155, visit 4			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0155	Female	5/15/12	Oral swab	Baseline	77		6381	17.5	2.38	N	N	N	Y	Y	other	R1158X	3849+10kbC>T	4																																																						
SRS6976539.SRR12184293	ECOCF0156, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0156	Female	12/15/11	Oral swab	Baseline			281	0.8		N	N	N	N	N	homozygous	F508del	F508del	1																																																						
SRS6976540.SRR12184292	ECOCF0156, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0156	Female	12/19/11	Oral swab				285	0.8							homozygous	F508del	F508del	2																																																						
SRS6976541.SRR12184291	ECOCF0157, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0157	Female	12/22/11	Oral swab	Baseline			2487	6.8		N	N	N	N	N	other	W1063X	F1099L	1																																																						
SRS6976805.SRR12184361	ECOCF0011, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0011	Male	2/24/10	Oral swab	Baseline			495	1.4		N	N	N	N	N	other	G542X	R117H	1																																																						
SRS6977058.SRR12184442	ECOCF0091, visit 3			V4	Human	GAZ:United States of America	Human	Lung	Bronchial tree and alveoli		ECOCF0091	Male	1/19/12	Bronchoalveolar lavage (BAL)	Baseline	103		5490	15	0.94	Y	Y	N	N	Y	homozygous	F508del	F508del	3																																																						
SRS6976542.SRR12184290	ECOCF0159, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0159	Male	2/7/12	Oral swab	Baseline	111		6096	16.7	4.52	N	N	N	N	Y	heterozygous	F508del		1																																																						
SRS6976544.SRR12184288	ECOCF0160, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0160	Male	4/13/12	Oral swab	Baseline			240	0.7		N	N	N	N	N	other	c.262_263delTT	c.[220C>T; 3808G>A]	1																																																						
SRS6976545.SRR12184287	ECOCF0160, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0160	Male	6/4/12	Oral swab	Baseline			292	0.8		N	N	N	N	N	other	c.262_263delTT	c.[220C>T; 3808G>A]	2																																																						
SRS6976546.SRR12184286	ECOCF0161, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0161	Male	5/17/12	Oral swab				3835	10.5		N	N	N	N	Y	heterozygous	F508del	L206W	1																																																						
SRS6976547.SRR12184285	ECOCF0162, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0162	Female	5/14/12	Oral swab	Baseline			784	2.1		N	N	N	N	N	homozygous	F508del	F508del	1																																																						
SRS6976806.SRR12184360	ECOCF0011, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0011	Male	8/31/10	Oral swab	Baseline			683	1.9		N	N	N	N	N	other	G542X	R117H	2																																																						
SRS6976807.SRR12184359	ECOCF0012, visit 1			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0012	Male	4/14/10	Sputum	Exacerbation (no treatment)	55		6948	19	2.43	Y	Y	N	Y	Y	heterozygous	F508del	G85E	1																																																						
SRS6976808.SRR12184358	ECOCF0013, visit 1			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0013	Female	3/1/10	Sputum	Exacerbation (no treatment)	57		5606	15.3	1.47	N	N	N	N	N	other	W1282X	W1282X	1																																																						
SRS6977299.SRR12184712	ECOCF0001, visit 6			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0001	Female	8/17/10	Sputum	Exacerbation (treatment with antibiotics)			6478	17.7		Y	Y	N	N	Y				6																																																						
SRS6976809.SRR12184357	ECOCF0013, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0013	Female	6/15/10	Oral swab	Baseline	65		5712	15.6	1.7	N	N	N	N	N	other	W1282X	W1282X	2																																																						
SRS6976810.SRR12184356	ECOCF0013, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0013	Female	2/22/12	Oral swab	Baseline			6329	17.3		N	N	N	N	N	other	W1282X	W1282X	3																																																						
SRS6976813.SRR12184353	ECOCF0014, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0014	Female	7/6/10	Oral swab	Baseline	81		3554	9.7	1.8	N	N	N	N	Y	heterozygous	F508del	1717-1G->A	1																																																						
SRS6976814.SRR12184352	ECOCF0014, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0014	Female	7/29/10	Oral swab	Exacerbation (treatment with antibiotics)	73		3577	9.8	1.63	N	N	N	N	Y	heterozygous	F508del	1717-1G->A	2																																																						
SRS6976812.SRR12184354	ECOCF0014, visit 3			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0014	Female	10/21/10	Sputum	Exacerbation (no treatment)	62		3661	10	1.4	N	N	N	N	Y	heterozygous	F508del	1717-1G->A	3																																																						
SRS6976815.SRR12184351	ECOCF0014, visit 4			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0014	Female	10/20/11	Oral swab	Exacerbation (no treatment)	94		4025	11	1.89	N	N	N	N	Y	heterozygous	F508del	1717-1G->A	4																																																						
SRS6976816.SRR12184350	ECOCF0015, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0015	Female	3/1/10	Oral swab	Baseline			6850	18.8		Y	N	N	N	Y	heterozygous	F508del	N1303K	1																																																						
SRS6976817.SRR12184349	ECOCF0015, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0015	Female	7/13/10	Oral swab	Baseline			6984	19.1		Y	N	N	N	Y	heterozygous	F508del	N1303K	2																																																						
SRS6977298.SRR12184711	ECOCF0002, visit 1			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0002	Male	2/23/10	Sputum	Baseline	124		7158	19.6	5.19	Y	Y	N	N	Y	other	G85E	I1234V	1																																																						
SRS6976818.SRR12184348	ECOCF0015, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0015	Female	9/21/10	Oral swab				7054	19.3		Y	N	N	N	Y	heterozygous	F508del	N1303K	3																																																						
SRS6976819.SRR12184347	ECOCF0015, visit 4			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0015	Female	10/29/10	Oral swab				7092	19.4		Y	N	N	N	Y	heterozygous	F508del	N1303K	4																																																						
SRS6976820.SRR12184346	ECOCF0016, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0016	Male	5/16/12	Oral swab				7419	20.3		Y	Y	N	N	Y	heterozygous	F508del	1717-1G->A	1																																																						
SRS6976513.SRR12184319	ECOCF0017, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0017	Male	3/2/10	Oral swab	Recovery (within 1 month after stopping antibiotics for exacerbation)	73		5054	13.8	1.92	Y	N	N	N	Y	heterozygous	F508del	G542X	1																																																						
SRS6976514.SRR12184318	ECOCF0017, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0017	Male	4/15/10	Oral swab	Exacerbation (treatment with antibiotics)	66		5098	14	1.73	Y	Y	N	N	Y	heterozygous	F508del	G542X	2																																																						
SRS6976515.SRR12184317	ECOCF0017, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0017	Male	5/25/10	Oral swab	Recovery (within 1 month after stopping antibiotics for exacerbation)	73		5138	14.1	1.96	Y	N	N	N	Y	heterozygous	F508del	G542X	3																																																						
SRS6976516.SRR12184316	ECOCF0017, visit 4			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0017	Male	8/10/10	Oral swab	Baseline	86		5215	14.3	2.42	Y	N	N	N	Y	heterozygous	F508del	G542X	4																																																						
SRS6976517.SRR12184315	ECOCF0017, visit 5			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0017	Male	10/5/10	Oral swab	Baseline	87		5271	14.4	2.53	Y	N	N	N	Y	heterozygous	F508del	G542X	5																																																						
SRS6976518.SRR12184314	ECOCF0017, visit 6			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0017	Male	11/9/10	Oral swab	Recovery (within 1 month after stopping antibiotics for exacerbation)	97		5306	14.5	2.85	Y	N	N	N	Y	heterozygous	F508del	G542X	6																																																						
SRS6977300.SRR12184710	ECOCF0002, visit 2			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0002	Male	6/15/10	Sputum	Baseline	129		7270	19.9	4.44	Y	Y	N	N	Y	other	G85E	I1234V	2																																																						
SRS6976519.SRR12184313	ECOCF0017, visit 7			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0017	Male	1/25/11	Oral swab	Exacerbation (treatment with antibiotics)	106		5383	14.7	3.21	Y	Y	N	N	Y	heterozygous	F508del	G542X	7																																																						
SRS6976520.SRR12184312	ECOCF0017, visit 8			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0017	Male	6/14/11	Oral swab	Exacerbation (treatment with antibiotics)	82		5523	15.1	2.67	Y	Y	N	N	Y	heterozygous	F508del	G542X	8																																																						
SRS6976521.SRR12184311	ECOCF0017, visit 9			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0017	Male	7/19/11	Oral swab	Recovery (within 1 month after stopping antibiotics for exacerbation)	91		5558	15.2	2.99	Y	Y	N	N	Y	heterozygous	F508del	G542X	9																																																						
SRS6976522.SRR12184310	ECOCF0017, visit 10			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0017	Male	9/9/11	Oral swab	Exacerbation (treatment with antibiotics)	80		5610	15.4	2.72	Y	Y	N	N	Y	heterozygous	F508del	G542X	10																																																						
SRS6976524.SRR12184308	ECOCF0017, visit 11			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0017	Male	12/22/11	Oral swab	Exacerbation (treatment with antibiotics)	93		5714	15.6	3.14	N	N	N	N	Y	heterozygous	F508del	G542X	11																																																						
SRS6976821.SRR12184345	ECOCF0017, visit 12			V4	Human	GAZ:United States of America	Human	Lung	Bronchial tree and alveoli		ECOCF0017	Male	3/9/12	Bronchoalveolar lavage (BAL)	Baseline	84		5792	15.9	2.89	Y	N	N	N	Y	heterozygous	F508del	G542X	12																																																						
SRS6976526.SRR12184306	ECOCF0018, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0018	Female	3/9/10	Oral swab	Exacerbation (treatment with antibiotics)	84		6493	17.8	2.61	N	N	N	N	Y	homozygous	F508del	F508del	1																																																						
SRS6976527.SRR12184305	ECOCF0018, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0018	Female	5/18/10	Oral swab	Baseline	82		6563	18	2.5	N	N	N	N	Y	homozygous	F508del	F508del	2																																																						
SRS6976488.SRR12184344	ECOCF0006, visit 11			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0006	Female	2/26/13	Oral swab	Baseline	77	Negative	5358	14.7							heterozygous	F508del	I507del	11	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976489.SRR12184343	ECOCF0165, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0165	Male	3/13/13	Oral swab	Recovery (within 1 month after stopping antibiotics for exacerbation)	77	Negative	3948	10.8							other	G542X	N1303K	1	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976995.SRR12184505	ECOCF0049, visit 5			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0049	Female	6/14/13	Oral swab	Baseline	94	Negative	6624	18.1							heterozygous	F508del	7T9T variant	5	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977227.SRR12184784	ECOCF0097, visit 7			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0097	Male	6/14/13	Oral swab	Exacerbation (no treatment)		Negative	1290	3.5							other	2184IrsA+	G1244E	7	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976534.SRR12184298	ECOCF0167, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0167	Male	6/26/13	Oral swab	Baseline	93	Negative	3959	10.8										1	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976673.SRR12184159	ECOCF0086, visit 6			V4	Human	GAZ:United States of America	Human	Lung	Bronchial tree and alveoli	Bronchoalveolar lavage fluid	ECOCF0086	Male	6/27/13	Bronchoalveolar lavage (BAL)	Recovery (within 1 month after stopping antibiotics for exacerbation)		Negative	5126	14		N	Y	N	N	Y	heterozygous	F508del	Q493X	6	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976887.SRR12184613	ECOCF0017, visit 13			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0017	Male	7/2/13	Oral swab	Exacerbation (treatment with antibiotics)	62	Negative	6272	17.2							heterozygous	F508del	G542X	13	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977117.SRR12184892	ECOCF0155, visit 5			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0155	Female	7/2/13	Oral swab	Baseline	80	Negative	6794	18.6							other	R1158X	3849+10kbC>T	5	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	Y	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977325.SRR12184685	ECOCF0165, visit 2			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0165	Male	6/28/13	Sputum	Exacerbation (no treatment)	59	Positive	4055	11.1							other	G542X	N1303K	2	N	N	N	N	N	N	Y	N	N	N	Y	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976553.SRR12184279	ECOCF0182, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0182	Female	2/12/14	Oral swab	Baseline		Negative	5079	13.9										1	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976490.SRR12184342	ECOCF0076, visit 8			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0076	Female	3/13/13	Oral swab	Exacerbation (treatment with antibiotics)	62	Negative	6152	16.9							other	3849+10kbC->T	W1282X	8	N	N	N	N	N	N	N	N	N	N	N	N	N																																									
SRS6976501.SRR12184331	ECOCF0151, visit 10			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0151	Female	6/28/13	Oral swab	Exacerbation (no treatment)	35	Negative	4555	12.5		Y	N	N	Y	Y	other	3120+1G->A	3120+1G->A	10	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976861.SRR12184641	ECOCF0122, visit 5			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0122	Female	7/11/13	Oral swab	Recovery (within 1 month after stopping antibiotics for exacerbation)	70	Positive	8135	22.3							heterozygous	F508del	N1303K	5	N	N	N	N	N	N	Y	N	N	N	Y	N	N	Y	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976870.SRR12184630	ECOCF0175, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0175	Female	7/12/13	Oral swab	Exacerbation (no treatment)		Positive	1198	3.3										1	N	N	N	N	N	N	Y	N	N	N	Y	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976881.SRR12184619	ECOCF0128, visit 6			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0128	Female	7/12/13	Oral swab	Baseline	78	Negative	5421	14.9		Y	Y	N	N	Y	other	I507del	A559T	6	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	Y	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976916.SRR12184584	ECOCF0165, visit 3			V4	Human	GAZ:United States of America	Human	Lung	Bronchial tree and alveoli		ECOCF0165	Male	7/10/13	Bronchoalveolar lavage (BAL)	Exacerbation (no treatment)		Negative	4067	11.1							other	G542X	N1303K	3	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976928.SRR12184573	ECOCF0037, visit 5			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0037	Male	7/16/13	Oral swab	Exacerbation (no treatment)	82	Negative	4068	11.1							homozygous	F508del	F508del	5	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976962.SRR12184538	ECOCF0151, visit 11			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0151	Female	7/11/13	Oral swab	Recovery (within 1 month after stopping antibiotics for exacerbation)	49	Negative	4568	12.5		Y	N	N	Y	Y	other	3120+1G->A	3120+1G->A	11	N	N	N	N	N	N	N	N	N	N	N	N	N																																									
SRS6976973.SRR12184527	ECOCF0152, visit 7			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0152	Male	7/11/13	Oral swab	Recovery (within 1 month after stopping antibiotics for exacerbation)	79	Negative	6189	17		Y	Y	N	N	Y	other	3120+1G->A	3120+1G->A	7	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976983.SRR12184516	ECOCF0183, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0183	Male	7/9/13	Oral swab	Baseline		Negative	904	2.5										1	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976996.SRR12184504	ECOCF0130, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0130	Female	7/18/13	Oral swab	Exacerbation (no treatment)		Negative	1091	3							heterozygous	F508del	I502T	1	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977029.SRR12184469	ECOCF0179, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0179	Male	7/18/13	Oral swab	Recovery (within 1 month after stopping antibiotics for exacerbation)	76	Negative	6061	16.6										1	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977042.SRR12184458	ECOCF0005, visit 8			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0005	Male	7/18/13	Oral swab	Baseline	73	Negative	5896	16.2		Y	Y	N	N	Y	homozygous	F508del	F508del	8	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977077.SRR12184933	ECOCF0138, visit 3			V4	Human	GAZ:United States of America	Human	Lung	Bronchial tree and alveoli		ECOCF0138	Male	7/22/13	Bronchoalveolar lavage (BAL)	Recovery (within 1 month after stopping antibiotics for exacerbation)		Negative	4982	13.6							homozygous	F508del	F508del	3	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977088.SRR12184922	ECOCF0081, visit 6			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0081	Male	7/23/13	Oral swab	Exacerbation (no treatment)	86	Negative	4486	12.3							homozygous	F508del	F508del	6	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977147.SRR12184863	ECOCF0061, visit 4			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0061	Male	7/26/13	Oral swab	Baseline	82	Negative	7061	19.3							heterozygous	F508del		4	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977158.SRR12184852	ECOCF0128, visit 4			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0128	Female	3/15/13	Oral swab	Exacerbation (no treatment)	66	Negative	5302	14.5		Y	Y	N	N	Y	other	I507del	A559T	4	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	Y	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977168.SRR12184841	ECOCF0062, visit 7			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0062	Female	7/26/13	Oral swab	Exacerbation (no treatment)	37	Negative	3830	10.5							heterozygous	F508del	R553X	7	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977205.SRR12184806	ECOCF0175, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0175	Female	7/26/13	Oral swab	Exacerbation (treatment with antibiotics)		Negative	1212	3.3										2	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977214.SRR12184795	ECOCF0049, visit 6			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0049	Female	7/26/13	Oral swab	Baseline	99	Negative	6666	18.3							heterozygous	F508del	7T9T variant	6	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977226.SRR12184783	ECOCF0179, visit 2			V4	Human	GAZ:United States of America	Human	Lung	Bronchial tree and alveoli		ECOCF0179	Male	7/29/13	Bronchoalveolar lavage (BAL)	Baseline		Negative	6072	16.6										2	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977238.SRR12184772	ECOCF0067, visit 8			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0067	Female	8/1/13	Oral swab	Exacerbation (no treatment)		Negative	1580	4.3							heterozygous	I507del	F508del	8	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977297.SRR12184713	ECOCF0123, visit 4			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0123	Male	8/2/13	Oral swab	Recovery (within 1 month after stopping antibiotics for exacerbation)		Negative	1848	5.1							other	Other		4	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977308.SRR12184702	ECOCF0097, visit 8			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0097	Male	8/2/13	Oral swab	Exacerbation (treatment with antibiotics)		Positive	1339	3.7							other	2184IrsA+	G1244E	8	N	N	N	N	N	N	Y	N	N	N	Y	N	N	N	Y	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976754.SRR12184412	ECOCF0160, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0160	Male	3/15/13	Oral swab	Baseline		Negative	4228	11.6		N	N	N	N	N	other	c.262_263delTT	c.[220C>T; 3808G>A]	3	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976765.SRR12184401	ECOCF0066, visit 7			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0066	Male	8/2/13	Oral swab	Baseline	105	Negative	3936	10.8							homozygous	F508del	F508del	7	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976800.SRR12184366	ECOCF0131, visit 5			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0131	Female	8/9/13	Oral swab	Recovery (within 1 month after stopping antibiotics for exacerbation)	127	Negative	1948	5.3		N	N	N	N	N	other	621+1G->T	Other	5	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976811.SRR12184355	ECOCF0009, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0009	Male	8/8/13	Oral swab	Baseline	67	Positive	4676	12.8							heterozygous	F508del		2	N	N	N	N	N	N	Y	N	N	N	Y	N	N																																									
SRS6976512.SRR12184320	ECOCF0128, visit 7			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0128	Female	8/16/13	Oral swab	Exacerbation (no treatment)	63	Positive	5456	14.9		Y	Y	N	N	Y	other	I507del	A559T	7	N	N	N	N	N	N	Y	N	N	N	Y	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976523.SRR12184309	ECOCF0062, visit 8			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0062	Female	8/16/13	Oral swab	Exacerbation (treatment with antibiotics)	40	Negative	3851	10.6							heterozygous	F508del	R553X	8	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976535.SRR12184297	ECOCF0072, visit 13			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0072	Male	8/16/13	Sputum	Recovery (within 1 month after stopping antibiotics for exacerbation)	34	Negative	3220	8.8							homozygous	F508del	F508del	13	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976570.SRR12184262	ECOCF0091, visit 6			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0091	Male	8/16/13	Oral swab	Baseline	75	Negative	6065	16.6							homozygous	F508del	F508del	6	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N
SRS6976581.SRR12184251	ECOCF0104, visit 6			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0104	Male	8/15/13	Oral swab	Baseline		Negative	1510	4.1							heterozygous	F508del	Other	6	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976596.SRR12184236	ECOCF0105, visit 7			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0105	Male	8/15/13	Oral swab	Baseline		Negative	1520	4.2							heterozygous	F508del	Other	7	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976607.SRR12184225	ECOCF0093, visit 6			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0093	Female	8/15/13	Oral swab	Baseline		Negative	2120	5.8							heterozygous	F508del	Other	6	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976618.SRR12184214	ECOCF0171, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0171	Female	8/8/13	Oral swab	Baseline	84	Negative	6206	17										1	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976629.SRR12184203	ECOCF0173, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0173	Female	8/16/13	Oral swab	Exacerbation (no treatment)	67	Positive	6189	17										3	N	N	N	N	N	N	Y	N	N	N	Y	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976640.SRR12184192	ECOCF0102, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0102	Male	8/19/13	Oral swab	Exacerbation (no treatment)	82	Negative	5870	16.1		Y	Y	N	N	Y	other	W1282X	G542X	3	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976651.SRR12184181	ECOCF0169, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0169	Male	8/5/13	Oral swab	Baseline	89	Negative	5718	15.7										1	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976662.SRR12184170	ECOCF0075, visit 3			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0075	Female	8/7/13	Sputum	Baseline	121	Negative	2314	6.3		N	N	N	N	N	homozygous	F508del	F508del	3	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976674.SRR12184158	ECOCF0157, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0157	Female	8/22/13	Oral swab	Baseline	94	Negative	3096	8.5		N	N	N	N	N	other	W1063X	F1099L	3	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976685.SRR12184147	ECOCF0094, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0094	Male	8/21/13	Oral swab	Baseline	83	Positive	3301	9							heterozygous	F508del		3	N	N	N	N	N	N	Y	N	N	N	Y	N	N	N	Y	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976696.SRR12184136	ECOCF0179, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0179	Male	8/23/13	Oral swab	Baseline	79	Negative	6097	16.7										3	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976707.SRR12184125	ECOCF0134, visit 10			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0134	Male	8/23/13	Sputum	Recovery (within 1 month after stopping antibiotics for exacerbation)	83	Negative	6542	17.9		Y	Y	N	N	Y	homozygous	F508del	F508del	10	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976718.SRR12184114	ECOCF0154, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0154	Male	3/14/13	Oral swab	Exacerbation (no treatment)		Positive	724	2		N	Y	N	N	N	homozygous	F508del	F508del	2	N	N	N	N	N	N	Y	N	N	N	Y	N	N	N	N	N	N	N	Y	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N
SRS6976729.SRR12184103	ECOCF0072, visit 14			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0072	Male	8/23/13	Sputum	Recovery (within 1 month after stopping antibiotics for exacerbation)	44	Negative	3227	8.8							homozygous	F508del	F508del	14	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976740.SRR12184092	ECOCF0050, visit 7			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0050	Male	8/27/13	Oral swab	Baseline	90	Negative	3456	9.5		N	N	N	N	N	heterozygous	F508del	A455E	7	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976830.SRR12184670	ECOCF0071, visit 7			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0071	Male	8/27/13	Oral swab	Baseline	106	Negative	4299	11.8							other	R560T	1717-1G->A	7	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976841.SRR12184659	ECOCF0172, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0172	Male	8/27/13	Oral swab	Baseline	116	Negative	2569	7										1	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	Y	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976851.SRR12184648	ECOCF0151, visit 12			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0151	Female	8/28/13	Sputum	Recovery (within 1 month after stopping antibiotics for exacerbation)	34	Negative	4616	12.6		Y	N	N	Y	Y	other	3120+1G->A	3120+1G->A	12	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	Y	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976888.SRR12184612	ECOCF0151, visit 13			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0151	Female	8/28/13	Oral swab	Recovery (within 1 month after stopping antibiotics for exacerbation)	34	Negative	4616	12.6		Y	N	N	Y	Y	other	3120+1G->A	3120+1G->A	13	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976899.SRR12184601	ECOCF0155, visit 6			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0155	Female	8/27/13	Sputum	Exacerbation (no treatment)	79	Positive	6850	18.8							other	R1158X	3849+10kbC>T	6	N	N	N	N	N	N	Y	N	N	N	Y	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	Y	N	N	N	N	N	N	N	N	N	N
SRS6976934.SRR12184566	ECOCF0177, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0177	Female	3/14/13	Oral swab	Recovery (within 1 month after stopping antibiotics for exacerbation)		Negative	96	0.3										1	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976946.SRR12184555	ECOCF0067, visit 9			V4	Human	GAZ:United States of America	Human	Lung	Bronchial tree and alveoli		ECOCF0067	Female	8/6/13	Bronchoalveolar lavage (BAL)	Baseline		Negative	1585	4.3							heterozygous	I507del	F508del	9	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977003.SRR12184496	ECOCF0033, visit 10			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0033	Female	8/30/13	Oral swab	Baseline	105	Negative	3444	9.4							heterozygous	F508del	1585-8G>A	10	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977018.SRR12184485	ECOCF0063, visit 7			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0063	Female	9/3/13	Oral swab	Exacerbation (no treatment)	96	Negative	2829	7.8		N	N	N	N	Y	other	p.5466x	p.Q1042x	7	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977026.SRR12184474	ECOCF0130, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0130	Female	9/6/13	Oral swab	Exacerbation (no treatment)		Negative	1141	3.1							heterozygous	F508del	I502T	2	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977061.SRR12184439	ECOCF0032, visit 9			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0032	Female	9/4/13	Oral swab	Exacerbation (no treatment)	80	Negative	5468	15							homozygous	F508del	F508del	9	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977072.SRR12184428	ECOCF0042, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0042	Female	9/4/13	Oral swab	Exacerbation (no treatment)	87	Negative	2450	6.7		N	Y	N	N	Y				3	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977107.SRR12184903	ECOCF0180, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0180	Male	9/10/13	Oral swab	Recovery (within 1 month after stopping antibiotics for exacerbation)	88	Negative	2235	6.1										2	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977119.SRR12184891	ECOCF0140, visit 4			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0140	Male	9/10/13	Oral swab	Baseline	78	Negative	4245	11.6							heterozygous	F508del	W1282X	4	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977130.SRR12184880	ECOCF0051, visit 6			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0051	Male	9/10/13	Oral swab	Baseline		Negative	5849	16							other	R560T	N1303K	6	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N
SRS6977142.SRR12184869	ECOCF0002, visit 6			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0002	Male	9/18/13	Sputum	Baseline	132	Negative	8461	23.2		Y	Y	N	N	Y	other	G85E	I1234V	6	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	Y	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977176.SRR12184834	ECOCF0106, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0106	Male	3/26/13	Oral swab	Baseline	108	Negative	4541	12.4		N	N	N	N	Y	homozygous	F508del	F508del	3	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N
SRS6977187.SRR12184823	ECOCF0002, visit 7			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0002	Male	9/18/13	Oral swab	Baseline	132	Negative	8461	23.2		Y	Y	N	N	Y	other	G85E	I1234V	7	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977246.SRR12184764	ECOCF0041, visit 9			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0041	Female	9/19/13	Oral swab	Exacerbation (no treatment)	68	Negative	8147	22.3							other	W1282X	W1282X	9	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977256.SRR12184753	ECOCF0110, visit 6			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0110	Female	9/19/13	Oral swab	Baseline	144	Negative	2081	5.7		N	N	N	N	N	heterozygous	F508del	Other	6	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977269.SRR12184742	ECOCF0007, visit 4			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0007	Female	9/19/13	Oral swab	Baseline	49	Negative	4051	11.1		N	N	N	N	N	other	R709X	Other	4	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977279.SRR12184731	ECOCF0151, visit 14			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0151	Female	9/23/13	Sputum	Recovery (within 1 month after stopping antibiotics for exacerbation)	33	Negative	4642	12.7		Y	N	N	Y	Y	other	3120+1G->A	3120+1G->A	14	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977290.SRR12184720	ECOCF0151, visit 15			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0151	Female	9/23/13	Oral swab	Recovery (within 1 month after stopping antibiotics for exacerbation)	33	Negative	4642	12.7		Y	N	N	Y	Y	other	3120+1G->A	3120+1G->A	15	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977326.SRR12184684	ECOCF0104, visit 7			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0104	Male	9/26/13	Oral swab	Baseline		Positive	1552	4.3							heterozygous	F508del	Other	7	N	N	N	N	N	N	Y	N	N	N	Y	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976748.SRR12184418	ECOCF0093, visit 7			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0093	Female	9/26/13	Oral swab	Exacerbation (no treatment)	108	Negative	2162	5.9							heterozygous	F508del	Other	7	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976783.SRR12184383	ECOCF0165, visit 4			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0165	Male	9/25/13	Sputum	Exacerbation (no treatment)	64	Negative	4144	11.4							other	G542X	N1303K	4	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976795.SRR12184372	ECOCF0165, visit 5			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0165	Male	9/25/13	Oral swab	Exacerbation (no treatment)	64	Negative	4144	11.4							other	G542X	N1303K	5	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976543.SRR12184289	ECOCF0060, visit 5			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0060	Female	9/26/13	Oral swab	Exacerbation (no treatment)	35	Negative	6043	16.6							heterozygous	F508del	M470V	5	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N
SRS6976548.SRR12184284	ECOCF0040, visit 8			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0040	Female	9/26/13	Oral swab	Baseline	97	Negative	1828	5							homozygous	F508del	F508del	8	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976549.SRR12184283	ECOCF0043, visit 7			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0043	Male	9/27/13	Oral swab	Baseline	109	Negative	2387	6.5										7	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976550.SRR12184282	ECOCF0167, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0167	Male	9/26/13	Oral swab	Baseline	86	Negative	4051	11.1										2	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976551.SRR12184281	ECOCF0005, visit 9			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0005	Male	9/26/13	Oral swab	Baseline	72	Negative	5966	16.3		Y	Y	N	N	Y	homozygous	F508del	F508del	9	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976552.SRR12184280	ECOCF0128, visit 8			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0128	Female	9/27/13	Oral swab	Recovery (within 1 month after stopping antibiotics for exacerbation)	81	Negative	5498	15.1		Y	Y	N	N	Y	other	I507del	A559T	8	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976554.SRR12184278	ECOCF0027, visit 4			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0027	Male	9/27/13	Oral swab	Baseline	122	Negative	3649	10							other	R334W		4	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976555.SRR12184277	ECOCF0152, visit 8			V4	Human	GAZ:United States of America	Human	Lung	Bronchial tree and alveoli		ECOCF0152	Male	9/26/13	Bronchoalveolar lavage (BAL)	Exacerbation (no treatment)	72	Negative	6266	17.2		Y	Y	N	N	Y	other	3120+1G->A	3120+1G->A	8	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976557.SRR12184276	ECOCF0132, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0132	Male	9/12/13	Oral swab	Baseline	96	Negative	5667	15.5		N	N	N	N	N	heterozygous	F508del	R553X	2	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976556.SRR12184275	ECOCF0130, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0130	Female	9/24/13	Oral swab	Recovery (within 1 month after stopping antibiotics for exacerbation)		Negative	1159	3.2							heterozygous	F508del	I502T	3	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	Y	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976558.SRR12184274	ECOCF0151, visit 7			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0151	Female	3/5/13	Sputum	Recovery (within 1 month after stopping antibiotics for exacerbation)	44	Positive	4440	12.2		Y	N	N	Y	Y	other	3120+1G->A	3120+1G->A	7	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	Y	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976559.SRR12184273	ECOCF0110, visit 4			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0110	Female	3/19/13	Oral swab	Baseline	125	Negative	1897	5.2		N	N	N	N	N	heterozygous	F508del	Other	4	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976584.SRR12184248	ECOCF0166, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0166	Female	10/24/13	Oral swab	Baseline	65	Negative	4773	13.1										2	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976586.SRR12184247	ECOCF0102, visit 4			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0102	Male	10/10/13	Oral swab	Recovery (within 1 month after stopping antibiotics for exacerbation)	78	Negative	5922	16.2		Y	Y	N	N	Y	other	W1282X	G542X	4	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976585.SRR12184246	ECOCF0154, visit 4			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0154	Female	10/10/13	Oral swab	Recovery (within 1 month after stopping antibiotics for exacerbation)		Negative	934	2.6		N	Y	N	N	N	homozygous	F508del	F508del	4	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976587.SRR12184245	ECOCF0131, visit 6			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0131	Male	10/3/13	Oral swab	Baseline	131	Positive	2003	5.5		N	N	N	N	N	other	621+1G->T	Other	6	N	N	N	N	N	N	Y	N	N	N	Y	N	N	Y	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976491.SRR12184341	ECOCF0122, visit 6			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0122	Male	10/10/13	Oral swab	Exacerbation (no treatment)	60	Negative	8226	22.5							heterozygous	F508del	N1303K	6	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976492.SRR12184340	ECOCF0169, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0169	Female	10/29/13	Oral swab	Baseline	81	Negative	5803	15.9										2	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976493.SRR12184339	ECOCF0021, visit 5			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0021	Female	10/23/13	Oral swab	Baseline	81	Negative	5834	16		N	N	N	N	N	heterozygous	R31C	F508del	5	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976494.SRR12184338	ECOCF0009, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0009	Male	10/5/13	Oral swab	Exacerbation (no treatment)		Negative	4734	13							heterozygous	F508del		3	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976495.SRR12184337	ECOCF0161, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0161	Male	10/3/13	Oral swab	Baseline	106	Negative	4339	11.9		N	N	N	N	Y	heterozygous	F508del	L206W	3	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976496.SRR12184336	ECOCF0063, visit 8			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0063	Female	10/3/13	Oral swab	Exacerbation (no treatment)	115	Negative	2859	7.8		N	N	N	N	Y	other	p.5466x	p.Q1042x	8	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	Y	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976497.SRR12184335	ECOCF0151, visit 8			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0151	Female	4/5/13	Sputum	Recovery (within 1 month after stopping antibiotics for exacerbation)	36	Negative	4471	12.2		Y	N	N	Y	Y	other	3120+1G->A	3120+1G->A	8	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N
SRS6976498.SRR12184334	ECOCF0076, visit 11			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0076	Female	10/22/13	Oral swab	Baseline	58	Negative	6375	17.5							other	3849+10kbC->T	W1282X	11	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N
SRS6976499.SRR12184333	ECOCF0024, visit 11			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0024	Male	10/16/13	Oral swab	Baseline	21	Negative	6607	18.1							other	W1282X	W1282X	11	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976500.SRR12184332	ECOCF0060, visit 6			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0060	Female	10/19/13	Oral swab	Recovery (within 1 month after stopping antibiotics for exacerbation)	66	Negative	6066	16.6							heterozygous	F508del	M470V	6	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976502.SRR12184330	ECOCF0177, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0177	Female	10/10/13	Oral swab	Recovery (within 1 month after stopping antibiotics for exacerbation)		Negative	307	0.8										2	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N
SRS6976503.SRR12184329	ECOCF0179, visit 4			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0179	Male	11/1/13	Oral swab	Baseline	87	Negative	6167	16.9										4	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976504.SRR12184328	ECOCF0044, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0044	Female	10/31/13	Oral swab	Baseline	84	Negative	8247	22.6							heterozygous	F508del	N1303K	3	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976505.SRR12184327	ECOCF0062, visit 9			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0062	Female	11/1/13	Oral swab	Baseline	39	Negative	3928	10.8							heterozygous	F508del	R553X	9	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976506.SRR12184326	ECOCF0122, visit 7			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0122	Female	10/31/13	Oral swab	Recovery (within 1 month after stopping antibiotics for exacerbation)	71	Negative	8247	22.6							heterozygous	F508del	N1303K	7	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976507.SRR12184325	ECOCF0156, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0156	Female	10/24/13	Oral swab	Baseline		Negative	960	2.6							homozygous	F508del	F508del	3	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	Y	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976508.SRR12184324	ECOCF0151, visit 9			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0151	Female	4/5/13	Oral swab	Recovery (within 1 month after stopping antibiotics for exacerbation)	36	Negative	4471	12.2		Y	N	N	Y	Y	other	3120+1G->A	3120+1G->A	9	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976509.SRR12184323	ECOCF0173, visit 4			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0173	Female	10/24/13	Oral swab	Baseline	64	Negative	6258	17.1										4	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976510.SRR12184322	ECOCF0066, visit 8			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0066	Male	11/1/13	Oral swab	Baseline		Negative	4027	11							homozygous	F508del	F508del	8	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976511.SRR12184321	ECOCF0162, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0162	Female	11/7/13	Oral swab	Baseline		Negative	1326	3.6		N	N	N	N	N	homozygous	F508del	F508del	2	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976860.SRR12184640	ECOCF0037, visit 6			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0037	Male	11/11/13	Oral swab	Baseline	101	Negative	4186	11.5							homozygous	F508del	F508del	6	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976859.SRR12184639	ECOCF0151, visit 16			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0151	Female	11/1/13	Oral swab	Exacerbation (no treatment)	31	Negative	4681	12.8		Y	N	N	Y	Y	other	3120+1G->A	3120+1G->A	16	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976863.SRR12184638	ECOCF0151, visit 17			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0151	Female	11/1/13	Sputum	Exacerbation (no treatment)	31	Negative	4681	12.8		Y	N	N	Y	Y	other	3120+1G->A	3120+1G->A	17	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	Y	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976862.SRR12184637	ECOCF0152, visit 9			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0152	Male	11/1/13	Oral swab	Exacerbation (treatment with antibiotics)		Negative	6302	17.3		Y	Y	N	N	Y	other	3120+1G->A	3120+1G->A	9	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976864.SRR12184636	ECOCF0159, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0159	Male	11/1/13	Oral swab	Baseline		Negative	6729	18.4		N	N	N	N	Y	heterozygous	F508del		3	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976866.SRR12184635	ECOCF0138, visit 4			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0138	Male	11/14/13	Oral swab	Exacerbation (no treatment)	50	Positive	5097	14							homozygous	F508del	F508del	4	N	N	N	N	N	N	Y	N	N	N	Y	N	N	Y	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976865.SRR12184634	ECOCF0123, visit 5			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0123	Male	10/29/13	Oral swab	Exacerbation (treatment with antibiotics)		Positive	1937	5.3							other	Other		5	N	N	N	N	N	N	Y	N	N	N	Y	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976868.SRR12184633	ECOCF0123, visit 6			V4	Human	GAZ:United States of America	Human	Lung	Bronchial tree and alveoli		ECOCF0123	Male	11/1/13	Bronchoalveolar lavage (BAL)	Exacerbation (treatment with antibiotics)		Positive	1940	5.3							other	Other		6	N	N	N	N	N	N	Y	N	N	N	Y	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976867.SRR12184632	ECOCF0017, visit 14			V4	Human	GAZ:United States of America	Human	Lung	Bronchial tree and alveoli		ECOCF0017	Male	10/30/13	Bronchoalveolar lavage (BAL)	Baseline	60	Positive	6392	17.5							heterozygous	F508del	G542X	14	N	N	N	N	N	N	Y	N	N	N	Y	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976869.SRR12184631	ECOCF0041, visit 10			V4	Human	GAZ:United States of America	Human	Lung	Bronchial tree and alveoli		ECOCF0041	Female	10/9/13	Bronchoalveolar lavage (BAL)	Recovery (within 1 month after stopping antibiotics for exacerbation)	67	Negative	8167	22.4							other	W1282X	W1282X	10	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	Y	N	N	N	N	N	N	N	N	Y	N	N	N	N	N
SRS6976871.SRR12184629	ECOCF0091, visit 7			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0091	Male	11/15/13	Oral swab	Baseline	71	Negative	6156	16.9							homozygous	F508del	F508del	7	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976872.SRR12184628	ECOCF0180, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0180	Female	11/12/13	Oral swab	Exacerbation (treatment with antibiotics)		Negative	2298	6.3										3	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976873.SRR12184627	ECOCF0017, visit 15			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0017	Male	11/15/13	Oral swab	Exacerbation (no treatment)	48	Negative	6408	17.6							heterozygous	F508del	G542X	15	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976874.SRR12184626	ECOCF0156, visit 4			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0156	Female	11/14/13	Oral swab	Exacerbation (no treatment)		Positive	981	2.7							homozygous	F508del	F508del	4	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976875.SRR12184625	ECOCF0108, visit 6			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0108	Female	4/9/13	Oral swab	Baseline	47	Negative	5468	15							heterozygous	F508del	A559T	6	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976876.SRR12184624	ECOCF0020, visit 5			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0020	Female	11/21/13	Oral swab	Exacerbation (no treatment)	52	Negative	6094	16.7		N	N	N	N	N	other	W1282X	W1282X	5	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976878.SRR12184623	ECOCF0013, visit 5			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0013	Female	11/21/13	Sputum	Baseline	59	Negative	6967	19.1		N	N	N	N	N	other	W1282X	W1282X	5	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976877.SRR12184622	ECOCF0095, visit 4			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0095	Female	11/21/13	Sputum	Exacerbation (no treatment)	65	Positive	4914	13.5							homozygous	F508del	F508del	4	N	N	N	N	N	N	Y	N	N	N	Y	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976879.SRR12184621	ECOCF0065, visit 1			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0065	Female	11/22/13	Sputum	Baseline	94	Negative	2293	6.3							heterozygous	F508del		1	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976880.SRR12184620	ECOCF0143, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0143	Female	11/22/13	Oral swab	Exacerbation (no treatment)		Negative	3239	8.9		N	N	N	N	N	other	4374+1G->T	Other	3	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976882.SRR12184618	ECOCF0090, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0090	Male	11/22/13	Oral swab	Baseline	101	Negative	4234	11.6		N	N	N	N	N	heterozygous	F508del		3	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976907.SRR12184593	ECOCF0043, visit 8			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0043	Male	11/13/13	Oral swab	Exacerbation (no treatment)		Negative	2448	6.7										8	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976908.SRR12184592	ECOCF0128, visit 5			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0128	Female	4/11/13	Oral swab	Recovery (within 1 month after stopping antibiotics for exacerbation)	73	Negative	5329	14.6		Y	Y	N	N	Y	other	I507del	A559T	5	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N
SRS6976909.SRR12184591	ECOCF0076, visit 9			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0076	Female	4/18/13	Sputum	Recovery (within 1 month after stopping antibiotics for exacerbation)	66	Negative	6188	17							other	3849+10kbC->T	W1282X	9	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N
SRS6976910.SRR12184590	ECOCF0076, visit 10			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0076	Female	4/18/13	Oral swab	Recovery (within 1 month after stopping antibiotics for exacerbation)	66	Negative	6188	17							other	3849+10kbC->T	W1282X	10	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976911.SRR12184589	ECOCF0152, visit 4			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0152	Male	3/5/13	Oral swab	Recovery (within 1 month after stopping antibiotics for exacerbation)	74	Positive	6061	16.6		Y	Y	N	N	Y	other	3120+1G->A	3120+1G->A	4	N	N	N	N	N	N	Y	N	N	N	Y	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976912.SRR12184588	ECOCF0040, visit 7			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0040	Female	4/16/13	Oral swab	Baseline		Negative	1665	4.6							homozygous	F508del	F508del	7	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N
SRS6976913.SRR12184587	ECOCF0074, visit 5			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0074	Female	4/19/13	Oral swab	Exacerbation (no treatment)		Negative	1623	4.4		N	N	N	N	N	homozygous	F508del	F508del	5	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976914.SRR12184586	ECOCF0131, visit 4			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0131	Female	4/19/13	Oral swab	Exacerbation (no treatment)	86	Negative	1836	5		N	N	N	N	N	other	621+1G->T	Other	4	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976915.SRR12184585	ECOCF0180, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0180	Female	4/18/13	Oral swab	Baseline		Positive	2090	5.7										1	N	N	N	N	N	N	Y	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976917.SRR12184583	ECOCF0067, visit 7			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0067	Female	4/24/13	Oral swab	Baseline		Negative	1481	4.1							heterozygous	I507del	F508del	7	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976918.SRR12184582	ECOCF0063, visit 6			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0063	Female	4/25/13	Oral swab	Baseline	116	Negative	2698	7.4		N	N	N	N	Y	other	p.5466x	p.Q1042x	6	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976919.SRR12184581	ECOCF0005, visit 7			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0005	Male	4/26/13	Oral swab	Baseline	79	Negative	5813	15.9		Y	Y	N	N	Y	homozygous	F508del	F508del	7	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976920.SRR12184580	ECOCF0093, visit 5			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0093	Female	4/26/13	Oral swab	Baseline		Negative	2009	5.5							heterozygous	F508del	Other	5	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976921.SRR12184579	ECOCF0105, visit 5			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0105	Male	4/26/13	Oral swab	Exacerbation (no treatment)		Positive	1409	3.9							heterozygous	F508del	Other	5	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	Y	N	N	N	Y	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976922.SRR12184578	ECOCF0104, visit 4			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0104	Male	4/26/13	Oral swab	Exacerbation (no treatment)		Positive	1399	3.8							heterozygous	F508del	Other	4	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	Y	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976923.SRR12184577	ECOCF0173, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0173	Female	4/26/13	Oral swab	Exacerbation (no treatment)	49	Negative	6077	16.6										1	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976924.SRR12184576	ECOCF0174, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0174	Male	4/30/13	Oral swab	Baseline		Negative	321	0.9										1	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976925.SRR12184575	ECOCF0009, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0009	Male	3/4/13	Oral swab	Exacerbation (no treatment)	55	Negative	4519	12.4							heterozygous	F508del		1	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976926.SRR12184574	ECOCF0072, visit 11			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0072	Male	4/30/13	Sputum	Exacerbation (no treatment)	36	Negative	3112	8.5							homozygous	F508del	F508del	11	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976927.SRR12184572	ECOCF0072, visit 12			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0072	Male	4/30/13	Oral swab	Exacerbation (no treatment)	36	Negative	3112	8.5							homozygous	F508del	F508del	12	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976929.SRR12184571	ECOCF0086, visit 5			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0086	Male	4/30/13	Oral swab	Exacerbation (no treatment)	69	Negative	5068	13.9		N	Y	N	N	Y	heterozygous	F508del	Q493X	5	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976930.SRR12184570	ECOCF0173, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0173	Female	4/30/13	Oral swab	Exacerbation (treatment with antibiotics)		Negative	6081	16.7										2	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976956.SRR12184545	ECOCF0133, visit 7			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0133	Male	5/3/13	Oral swab	Exacerbation (no treatment)	71	Positive	5684	15.6		Y	Y	N	N	Y	homozygous	F508del	F508del	7	N	N	N	N	N	N	Y	N	N	N	Y	N	N	N	Y	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976955.SRR12184544	ECOCF0133, visit 8			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0133	Male	5/3/13	Sputum	Exacerbation (no treatment)	71	Positive	5684	15.6		Y	Y	N	N	Y	homozygous	F508del	F508del	8	N	N	N	N	N	N	Y	N	N	N	Y	N	N	N	Y	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976957.SRR12184543	ECOCF0134, visit 8			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0134	Male	5/3/13	Sputum	Exacerbation (no treatment)	84	Negative	6430	17.6		Y	Y	N	N	Y	homozygous	F508del	F508del	8	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976959.SRR12184542	ECOCF0134, visit 9			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0134	Male	5/3/13	Oral swab	Exacerbation (no treatment)	84	Negative	6430	17.6		Y	Y	N	N	Y	homozygous	F508del	F508del	9	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976960.SRR12184541	ECOCF0062, visit 5			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0062	Female	5/3/13	Oral swab	Exacerbation (no treatment)	44	Negative	3746	10.3							heterozygous	F508del	R553X	5	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976958.SRR12184540	ECOCF0154, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0154	Male	5/3/13	Oral swab	Recovery (within 1 month after stopping antibiotics for exacerbation)		Negative	774	2.1		N	Y	N	N	N	homozygous	F508del	F508del	3	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N
SRS6976961.SRR12184539	ECOCF0109, visit 6			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0109	Male	5/8/13	Oral swab	Baseline		Negative	6135	16.8		N	Y	N	N	Y	heterozygous	F508del	W1282X	6	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N
SRS6976963.SRR12184537	ECOCF0024, visit 10			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0024	Male	5/30/13	Oral swab	Baseline	22	Negative	6468	17.7							other	W1282X	W1282X	10	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N
SRS6976964.SRR12184536	ECOCF0041, visit 7			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0041	Female	5/30/13	Sputum	Exacerbation (no treatment)	51	Negative	8035	22							other	W1282X	W1282X	7	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976965.SRR12184535	ECOCF0033, visit 9			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0033	Female	5/17/13	Oral swab	Baseline	99	Negative	3339	9.1							heterozygous	F508del	1585-8G>A	9	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N
SRS6976966.SRR12184534	ECOCF0067, visit 6			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0067	Female	2/19/13	Oral swab	Exacerbation (no treatment)		Negative	1417	3.9							heterozygous	I507del	F508del	6	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	Y	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976967.SRR12184533	ECOCF0152, visit 5			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0152	Male	5/10/13	Oral swab	Baseline	69	Positive	6127	16.8		Y	Y	N	N	Y	other	3120+1G->A	3120+1G->A	5	N	N	N	N	N	N	Y	N	N	N	Y	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976968.SRR12184532	ECOCF0064, visit 5			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0064	Female	5/14/14	Oral swab	Baseline		Negative	1224	3.4		N	N	N	N	N	heterozygous	F508del	R74W	5	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976969.SRR12184531	ECOCF0159, visit 2			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0159	Male	5/17/13	Sputum	Exacerbation (no treatment)	98	Negative	6561	18		N	N	N	N	Y	heterozygous	F508del		2	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976970.SRR12184530	ECOCF0043, visit 6			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0043	Male	5/24/13	Oral swab	Exacerbation (no treatment)	129	Positive	2261	6.2										6	N	N	N	N	N	N	Y	N	N	N	Y	N	N	N	Y	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976971.SRR12184529	ECOCF0161, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0161	Male	5/29/13	Oral swab	Baseline	92	Negative	4212	11.5		N	N	N	N	Y	heterozygous	F508del	L206W	2	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976972.SRR12184528	ECOCF0122, visit 4			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0122	Female	6/3/13	Sputum	Exacerbation (no treatment)	36	Negative	8097	22.2							heterozygous	F508del	N1303K	4	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976976.SRR12184526	ECOCF0178, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0178	Female	6/4/13	Oral swab	Baseline		Negative	252	0.7										1	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976975.SRR12184525	ECOCF0013, visit 4			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0013	Female	6/4/13	Oral swab	Baseline	64	Negative	6797	18.6		N	N	N	N	N	other	W1282X	W1282X	4	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976974.SRR12184524	ECOCF0020, visit 4			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0020	Female	6/4/13	Oral swab	Exacerbation (no treatment)	70	Negative	5924	16.2		N	N	N	N	N	other	W1282X	W1282X	4	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976977.SRR12184523	ECOCF0104, visit 5			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0104	Male	6/4/13	Oral swab	Recovery (within 1 month after stopping antibiotics for exacerbation)		Negative	1438	3.9							heterozygous	F508del	Other	5	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976978.SRR12184522	ECOCF0105, visit 6			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0105	Male	6/4/13	Oral swab	Exacerbation (no treatment)		Positive	1448	4							heterozygous	F508del	Other	6	N	N	N	N	N	N	Y	N	N	N	Y	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976979.SRR12184521	ECOCF0166, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0166	Female	6/7/13	Oral swab	Baseline	71	Negative	4634	12.7										1	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976980.SRR12184520	ECOCF0039, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0039	Male	6/10/13	Oral swab	Baseline	95	Negative	2317	6.3		N	Y	N	N	Y	homozygous	F508del	F508del	3	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	Y	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976981.SRR12184519	ECOCF0062, visit 6			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0062	Female	6/11/13	Oral swab	Exacerbation (treatment with antibiotics)	34	Positive	3785	10.4							heterozygous	F508del	R553X	6	N	N	N	N	N	N	N	N	N	N	N	N	Y	Y	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976982.SRR12184518	ECOCF0181, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0181	Female	6/11/13	Oral swab	Exacerbation (treatment with antibiotics)		Positive	320	0.9										1	N	N	N	N	N	N	Y	N	N	N	Y	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	Y	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976984.SRR12184517	ECOCF0157, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0157	Female	6/19/13	Oral swab	Recovery (within 1 month after stopping antibiotics for exacerbation)	95	Negative	3032	8.3		N	N	N	N	N	other	W1063X	F1099L	2	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	Y	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976985.SRR12184515	ECOCF0110, visit 5			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0110	Female	6/20/13	Oral swab	Baseline	135	Negative	1990	5.5		N	N	N	N	N	heterozygous	F508del	Other	5	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	Y	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976986.SRR12184514	ECOCF0152, visit 6			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0152	Male	6/17/13	Sputum	Exacerbation (no treatment)	69	Negative	6165	16.9		Y	Y	N	N	Y	other	3120+1G->A	3120+1G->A	6	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976987.SRR12184513	ECOCF0041, visit 8			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0041	Female	6/21/13	Oral swab	Recovery (within 1 month after stopping antibiotics for exacerbation)	77	Negative	8057	22.1							other	W1282X	W1282X	8	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976988.SRR12184512	ECOCF0021, visit 4			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0021	Female	6/21/13	Oral swab	Baseline	102	Negative	5710	15.6		N	N	N	N	N	heterozygous	R31C	F508del	4	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976989.SRR12184511	ECOCF0102, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0102	Male	6/14/13	Oral swab	Baseline	83	Negative	5804	15.9		Y	Y	N	N	Y	other	W1282X	G542X	2	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N
SRS6976990.SRR12184510	ECOCF0002, visit 8			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0002	Male	12/11/13	Oral swab	Baseline	116	Negative	8545	23.4		Y	Y	N	N	Y	other	G85E	I1234V	8	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976991.SRR12184509	ECOCF0131, visit 7			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0131	Female	4/2/14	Oral swab	Baseline	87	Negative	2184	6		N	N	N	N	N	other	621+1G->T	Other	7	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976992.SRR12184508	ECOCF0132, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0132	Male	4/1/14	Oral swab	Baseline	95	Negative	5868	16.1		N	N	N	N	N	heterozygous	F508del	R553X	3	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976993.SRR12184507	ECOCF0133, visit 9			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0133	Male	12/6/13	Sputum	Exacerbation (no treatment)	73	Negative	5901	16.2		Y	Y	N	N	Y	homozygous	F508del	F508del	9	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976994.SRR12184506	ECOCF0134, visit 11			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0134	Male	12/6/13	Sputum	Exacerbation (no treatment)	68	Negative	6647	18.2		Y	Y	N	N	Y	homozygous	F508del	F508del	11	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976997.SRR12184503	ECOCF0140, visit 5			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0140	Male	2/18/14	Oral swab	Baseline		Negative	4406	12.1							heterozygous	F508del	W1282X	5	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976998.SRR12184502	ECOCF0144, visit 5			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0144	Female	2/12/14	Oral swab	Baseline		Negative	4003	11							other	1540A>G	1716+63ins11	5	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6976999.SRR12184501	ECOCF0151, visit 18			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0151	Female	1/3/14	Sputum	Exacerbation (no treatment)	30	Negative	4744	13		Y	N	N	Y	Y	other	3120+1G->A	3120+1G->A	18	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977000.SRR12184500	ECOCF0151, visit 19			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0151	Female	2/14/14	Oral swab	Recovery (within 1 month after stopping antibiotics for exacerbation)	38	Negative	4786	13.1		Y	N	N	Y	Y	other	3120+1G->A	3120+1G->A	19	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977001.SRR12184499	ECOCF0151, visit 20			V4	Human	GAZ:United States of America	Human	Lung	Bronchial tree and alveoli		ECOCF0151	Female	3/26/14	Bronchoalveolar lavage (BAL)	Exacerbation (treatment with antibiotics)	29	Negative	4826	13.2		Y	N	N	Y	Y	other	3120+1G->A	3120+1G->A	20	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977002.SRR12184498	ECOCF0152, visit 10			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0152	Male	12/11/13	Oral swab	Exacerbation (no treatment)		Positive	6342	17.4		Y	Y	N	N	Y	other	3120+1G->A	3120+1G->A	10	N	N	N	N	N	N	N	N	N	N	N	Y	N	Y	N	N	N	N	N	N	Y	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977027.SRR12184473	ECOCF0152, visit 11			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0152	Male	4/4/14	Oral swab	Recovery (within 1 month after stopping antibiotics for exacerbation)	73	Negative	6456	17.7		Y	Y	N	N	Y	other	3120+1G->A	3120+1G->A	11	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977028.SRR12184472	ECOCF0154, visit 5			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0154	Male	3/31/14	Oral swab	Exacerbation (no treatment)		Negative	1106	3		N	Y	N	N	N	homozygous	F508del	F508del	5	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977030.SRR12184471	ECOCF0156, visit 5			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0156	Female	5/29/14	Oral swab	Exacerbation (no treatment)		Negative	1177	3.2							homozygous	F508del	F508del	5	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977031.SRR12184470	ECOCF0157, visit 4			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0157	Female	12/12/13	Oral swab	Baseline	99	Negative	3208	8.8		N	N	N	N	N	other	W1063X	F1099L	4	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977032.SRR12184468	ECOCF0161, visit 4			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0161	Male	12/5/13	Oral swab	Baseline	87	Negative	4402	12.1		N	N	N	N	Y	heterozygous	F508del	L206W	4	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977033.SRR12184467	ECOCF0161, visit 5			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0161	Male	3/6/14	Oral swab	Baseline	102	Negative	4493	12.3		N	N	N	N	Y	heterozygous	F508del	L206W	5	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977035.SRR12184466	ECOCF0165, visit 6			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0165	Male	12/27/13	Oral swab	Baseline	64	Negative	4237	11.6							other	G542X	N1303K	6	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977034.SRR12184465	ECOCF0165, visit 7			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0165	Male	12/27/13	Sputum	Baseline	64	Negative	4237	11.6							other	G542X	N1303K	7	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977036.SRR12184464	ECOCF0165, visit 8			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0165	Male	3/23/14	Oral swab	Baseline	63	Negative	4323	11.8							other	G542X	N1303K	8	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977037.SRR12184463	ECOCF0165, visit 9			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0165	Male	5/21/14	Oral swab	Recovery (within 1 month after stopping antibiotics for exacerbation)	64	Negative	4382	12							other	G542X	N1303K	9	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977038.SRR12184462	ECOCF0167, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0167	Male	2/27/14	Oral swab	Baseline		Positive	4205	11.5										3	N	Y	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977040.SRR12184461	ECOCF0167, visit 4			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0167	Male	4/10/14	Oral swab	Baseline	92	Negative	4247	11.6										4	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977039.SRR12184460	ECOCF0171, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0171	Female	12/6/13	Oral swab	Recovery (within 1 month after stopping antibiotics for exacerbation)	75	Negative	6326	17.3										2	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977041.SRR12184459	ECOCF0171, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0171	Female	12/14/13	Oral swab	Exacerbation (treatment with antibiotics)		Negative	6334	17.4										3	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977043.SRR12184457	ECOCF0021, visit 6			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0021	Female	1/15/14	Oral swab	Baseline		Negative	5918	16.2		N	N	N	N	N	heterozygous	R31C	F508del	6	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977045.SRR12184456	ECOCF0171, visit 4			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0171	Female	1/30/14	Oral swab	Baseline	83	Negative	6381	17.5										4	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977044.SRR12184455	ECOCF0172, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0172	Male	4/1/14	Oral swab	Exacerbation (treatment with antibiotics)	110	Negative	2786	7.6										2	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977046.SRR12184454	ECOCF0173, visit 5			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0173	Female	12/9/13	Sputum	Recovery (within 1 month after stopping antibiotics for exacerbation)		Negative	6304	17.3										5	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977047.SRR12184453	ECOCF0173, visit 6			V4	Human	GAZ:United States of America	Human	Lung	Bronchial tree and alveoli		ECOCF0173	Female	3/4/14	Bronchoalveolar lavage (BAL)	Exacerbation (treatment with antibiotics)		Positive	6389	17.5										6	N	N	N	N	N	N	Y	N	N	N	Y	N	N	N	Y	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977049.SRR12184452	ECOCF0173, visit 7			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0173	Female	4/8/14	Sputum	Exacerbation (treatment with antibiotics)	61	Negative	6424	17.6										7	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977048.SRR12184451	ECOCF0175, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0175	Female	12/13/13	Oral swab	Exacerbation (no treatment)		Positive	1352	3.7										3	N	N	N	N	N	Y	Y	N	N	N	Y	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977050.SRR12184450	ECOCF0175, visit 4			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0175	Female	2/14/14	Oral swab	Baseline		Negative	1415	3.9										4	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977075.SRR12184425	ECOCF0176, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0176	Male	2/25/14	Oral swab	Recovery (within 1 month after stopping antibiotics for exacerbation)	128	Negative	4778	13.1										1	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977076.SRR12184424	ECOCF0177, visit 3			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0177	Female	12/18/13	Oral swab	Baseline		Positive	376	1										3	N	N	N	N	N	N	Y	N	N	N	Y	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977078.SRR12184932	ECOCF0179, visit 5			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0179	Male	1/31/14	Oral swab	Baseline		Positive	6258	17.1										5	N	N	N	N	N	N	Y	N	N	N	Y	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977079.SRR12184931	ECOCF0179, visit 6			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0179	Male	4/4/14	Oral swab	Baseline	73	Positive	6321	17.3										6	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977080.SRR12184930	ECOCF0182, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0182	Female	1/8/14	Oral swab	Baseline		Positive	5273	14.4										2	N	N	N	N	N	N	Y	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977081.SRR12184929	ECOCF0183, visit 2			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0183	Male	12/16/13	Oral swab	Exacerbation (no treatment)		Positive	1064	2.9										2	N	N	N	N	N	N	Y	N	N	N	Y	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977082.SRR12184928	ECOCF0024, visit 12			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0024	Male	1/17/14	Oral swab	Recovery (within 1 month after stopping antibiotics for exacerbation)		Positive	6700	18.4							other	W1282X	W1282X	12	N	N	N	N	N	N	Y	N	N	N	Y	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977083.SRR12184927	ECOCF0184, visit 1			V4	Human	GAZ:United States of America	Human	Lung	Bronchial tree and alveoli		ECOCF0184	Male	3/12/14	Bronchoalveolar lavage (BAL)	Exacerbation (no treatment)		Negative	118	0.3										1	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977085.SRR12184926	ECOCF0185, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0185	Male	3/28/14	Oral swab	Baseline	108	Positive	2857	7.8										1	N	N	N	N	N	N	Y	N	N	N	Y	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977084.SRR12184925	ECOCF0186, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0186	Male	3/28/14	Oral swab	Baseline	93	Negative	4195	11.5										1	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977086.SRR12184924	ECOCF0187, visit 1			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0187	Male	3/13/14	Oral swab	Recovery (within 1 month after stopping antibiotics for exacerbation)		Negative	6892	18.9										1	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977087.SRR12184923	ECOCF0027, visit 6			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0027	Male	4/29/14	Oral swab	Recovery (within 1 month after stopping antibiotics for exacerbation)		Negative	3863	10.6							other	R334W		6	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977089.SRR12184921	ECOCF0109, visit 8			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0109	Male	4/28/14	Oral swab	Baseline	83	Negative	6490	17.8		N	Y	N	N	Y	heterozygous	F508del	W1282X	8	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977091.SRR12184920	ECOCF0151, visit 21			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0151	Female	4/25/14	Oral swab	Recovery (within 1 month after stopping antibiotics for exacerbation)	37	Negative	4856	13.3		Y	N	N	Y	Y	other	3120+1G->A	3120+1G->A	21	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977090.SRR12184919	ECOCF0171, visit 5			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0171	Female	4/24/14	Oral swab	Baseline	85	Negative	6465	17.7										5	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977092.SRR12184918	ECOCF0024, visit 13			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0024	Male	3/21/14	Oral swab	Baseline	21	Negative	6763	18.5							other	W1282X	W1282X	13	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N
SRS6977093.SRR12184917	ECOCF0175, visit 5			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0175	Female	5/2/14	Oral swab	Exacerbation (no treatment)		Negative	1492	4.1										5	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977094.SRR12184916	ECOCF0024, visit 14			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0024	Male	5/29/14	Oral swab	Exacerbation (treatment with antibiotics)	22	Positive	6832	18.7							other	W1282X	W1282X	14	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977095.SRR12184915	ECOCF0027, visit 5			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0027	Male	1/2/14	Oral swab	Exacerbation (no treatment)		Positive	3746	10.3							other	R334W		5	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977096.SRR12184914	ECOCF0029, visit 5			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0029	Male	2/21/14	Oral swab	Baseline		Negative	2173	6		N	N	N	N	N	heterozygous	F508del	Other	5	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977097.SRR12184913	ECOCF0031, visit 4			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0031	Female	4/1/14	Oral swab	Baseline	103	Negative	4987	13.7							heterozygous	F508del	V520F	4	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977099.SRR12184912	ECOCF0032, visit 10			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0032	Female	12/6/13	Oral swab	Baseline	82	Negative	5561	15.2							homozygous	F508del	F508del	10	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977148.SRR12184862	ECOCF0032, visit 11			V4	Human	GAZ:United States of America	Human	Lung	Bronchial tree and alveoli		ECOCF0032	Female	1/8/14	Bronchoalveolar lavage (BAL)	Exacerbation (no treatment)		Negative	5594	15.3							homozygous	F508del	F508del	11	N	N	N	N	N	N	N	N	N	N	N	N	N																																									
SRS6977149.SRR12184861	ECOCF0033, visit 11			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0033	Female	12/4/13	Oral swab	Baseline	85	Negative	3540	9.7							heterozygous	F508del	1585-8G>A	11	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977151.SRR12184860	ECOCF0033, visit 12			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0033	Female	2/20/14	Oral swab	Baseline	105	Negative	3618	9.9							heterozygous	F508del	1585-8G>A	12	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977150.SRR12184859	ECOCF0037, visit 7			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0037	Male	2/11/14	Oral swab	Baseline		Positive	4278	11.7							homozygous	F508del	F508del	7	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977152.SRR12184858	ECOCF0039, visit 6			V4	Human	GAZ:United States of America	Human	Lung	Bronchial tree and alveoli		ECOCF0039	Male	3/12/14	Bronchoalveolar lavage (BAL)	Exacerbation (treatment with antibiotics)		Positive	2592	7.1		N	Y	N	N	Y	homozygous	F508del	F508del	6	N	N	N	N	N	N	N	N	Y	Y	N	N	N	N	Y	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977153.SRR12184857	ECOCF0040, visit 9			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0040	Female	1/21/14	Oral swab	Baseline		Negative	1945	5.3							homozygous	F508del	F508del	9	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977154.SRR12184856	ECOCF0005, visit 10			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0005	Male	2/4/14	Oral swab	Baseline		Negative	6097	16.7		Y	Y	N	N	Y	homozygous	F508del	F508del	10	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977155.SRR12184855	ECOCF0040, visit 10			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0040	Female	4/9/14	Oral swab	Baseline		Negative	2023	5.5							homozygous	F508del	F508del	10	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977156.SRR12184854	ECOCF0042, visit 4			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0042	Female	12/19/13	Oral swab	Exacerbation (no treatment)	82	Negative	2556	7		N	Y	N	N	Y				4	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977157.SRR12184853	ECOCF0042, visit 5			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0042	Female	1/16/14	Oral swab	Recovery (within 1 month after stopping antibiotics for exacerbation)	67	Positive	2584	7.1		N	Y	N	N	Y				5	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977159.SRR12184851	ECOCF0042, visit 6			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0042	Female	3/12/14	Oral swab	Exacerbation (treatment with antibiotics)		Negative	2639	7.2		N	Y	N	N	Y				6	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977160.SRR12184850	ECOCF0043, visit 9			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0043	Male	2/7/14	Oral swab	Baseline		Negative	2534	6.9										9	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977161.SRR12184849	ECOCF0043, visit 10			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0043	Male	5/30/14	Oral swab	Baseline	111	Negative	2646	7.2										10	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977162.SRR12184848	ECOCF0049, visit 7			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0049	Female	12/20/13	Oral swab	Baseline	97	Negative	6813	18.7							heterozygous	F508del	7T9T variant	7	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977163.SRR12184847	ECOCF0051, visit 7			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0051	Male	2/11/14	Oral swab	Baseline		Positive	6003	16.4							other	R560T	N1303K	7	N	N	Y	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977164.SRR12184846	ECOCF0056, visit 5			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0056	Male	12/23/13	Oral swab	Baseline	91	Negative	6798	18.6		N	N	N	N	Y				5	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977165.SRR12184845	ECOCF0060, visit 7			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0060	Female	1/10/14	Oral swab	Exacerbation (treatment with antibiotics)		Negative	6149	16.8							heterozygous	F508del	M470V	7	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977166.SRR12184844	ECOCF0060, visit 8			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0060	Female	1/29/14	Oral swab	Recovery (within 1 month after stopping antibiotics for exacerbation)		Negative	6168	16.9							heterozygous	F508del	M470V	8	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977167.SRR12184843	ECOCF0062, visit 10			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0062	Female	1/17/14	Oral swab	Exacerbation (treatment with antibiotics)		Positive	4005	11							heterozygous	F508del	R553X	10	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977170.SRR12184842	ECOCF0062, visit 11			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0062	Female	4/18/14	Oral swab	Exacerbation (no treatment)	34	Positive	4096	11.2							heterozygous	F508del	R553X	11	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977169.SRR12184840	ECOCF0063, visit 9			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0063	Female	3/13/14	Oral swab	Baseline		Negative	3020	8.3		N	N	N	N	Y	other	p.5466x	p.Q1042x	9	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N
SRS6977196.SRR12184815	ECOCF0064, visit 6			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0064	Female	12/27/13	Oral swab	Baseline		Positive	1451	4		N	N	N	N	N	heterozygous	F508del	R74W	6	N	N	N	N	N	N	Y	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977195.SRR12184814	ECOCF0064, visit 7			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0064	Female	1/24/14	Oral swab	Baseline		Negative	1479	4.1		N	N	N	N	N	heterozygous	F508del	R74W	7	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977197.SRR12184813	ECOCF0064, visit 8			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0064	Female	3/28/14	Oral swab	Baseline		Negative	1542	4.2		N	N	N	N	N	heterozygous	F508del	R74W	8	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977198.SRR12184812	ECOCF0065, visit 2			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0065	Female	2/14/14	Sputum	Exacerbation (no treatment)		Positive	2377	6.5							heterozygous	F508del		2	N	N	N	N	N	N	Y	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977200.SRR12184811	ECOCF0067, visit 10			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0067	Female	1/24/14	Oral swab	Exacerbation (no treatment)		Negative	1756	4.8							heterozygous	I507del	F508del	10	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977199.SRR12184810	ECOCF0067, visit 11			V4	Human	GAZ:United States of America	Human	Lung	Bronchial tree and alveoli		ECOCF0067	Female	2/24/14	Bronchoalveolar lavage (BAL)	Exacerbation (treatment with antibiotics)		Negative	1787	4.9							heterozygous	I507del	F508del	11	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977201.SRR12184809	ECOCF0071, visit 8			V4	Human	GAZ:United States of America	Human	Lung	Bronchial tree and alveoli		ECOCF0071	Male	12/10/13	Bronchoalveolar lavage (BAL)	Recovery (within 1 month after stopping antibiotics for exacerbation)		Positive	4404	12.1							other	R560T	1717-1G->A	8	N	N	N	N	N	N	Y	N	N	N	Y	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977202.SRR12184808	ECOCF0071, visit 9			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0071	Male	1/28/14	Oral swab	Baseline	103	Positive	4453	12.2							other	R560T	1717-1G->A	9	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977203.SRR12184807	ECOCF0072, visit 15			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0072	Male	2/19/14	Sputum	Exacerbation (no treatment)		Positive	3407	9.3							homozygous	F508del	F508del	15	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977204.SRR12184805	ECOCF0074, visit 6			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0074	Female	2/28/14	Oral swab	Baseline		Negative	1938	5.3		N	N	N	N	N	homozygous	F508del	F508del	6	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977206.SRR12184804	ECOCF0017, visit 16			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0017	Male	2/27/14	Oral swab	Baseline	62	Negative	6512	17.8							heterozygous	F508del	G542X	16	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977208.SRR12184803	ECOCF0074, visit 7			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0074	Female	5/30/14	Oral swab	Baseline	85	Negative	2029	5.6		N	N	N	N	N	homozygous	F508del	F508del	7	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977210.SRR12184802	ECOCF0081, visit 7			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0081	Male	1/9/14	Oral swab	Exacerbation (no treatment)		Negative	4656	12.8							homozygous	F508del	F508del	7	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977207.SRR12184801	ECOCF0081, visit 8			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0081	Male	6/5/14	Oral swab	Exacerbation (no treatment)	84	Negative	4803	13.2							homozygous	F508del	F508del	8	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977209.SRR12184800	ECOCF0091, visit 10			V4	Human	GAZ:United States of America	Human	Lung	Bronchial tree and alveoli		ECOCF0091	Male	3/18/14	Bronchoalveolar lavage (BAL)	Exacerbation (no treatment)		Negative	6279	17.2							homozygous	F508del	F508del	10	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977211.SRR12184799	ECOCF0091, visit 8			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0091	Male	1/31/14	Oral swab	Exacerbation (no treatment)		Negative	6233	17.1							homozygous	F508del	F508del	8	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977212.SRR12184798	ECOCF0091, visit 9			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0091	Male	3/14/14	Oral swab	Exacerbation (no treatment)		Positive	6275	17.2							homozygous	F508del	F508del	9	N	N	N	N	N	N	N	Y	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977213.SRR12184797	ECOCF0091, visit 11			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0091	Male	5/2/14	Sputum	Baseline		Negative	6324	17.3							homozygous	F508del	F508del	11	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977215.SRR12184796	ECOCF0093, visit 8			V4	Human	GAZ:United States of America	Human	Lung	Bronchial tree and alveoli		ECOCF0093	Female	12/4/13	Bronchoalveolar lavage (BAL)	Exacerbation (no treatment)		Positive	2231	6.1							heterozygous	F508del	Other	8														N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977216.SRR12184794	ECOCF0093, visit 9			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0093	Female	3/13/14	Oral swab	Exacerbation (no treatment)		Positive	2330	6.4							heterozygous	F508del	Other	9	N	N	N	N	N	N	Y	N	N	N	Y	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977217.SRR12184793	ECOCF0095, visit 5			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0095	Female	1/2/14	Sputum	Recovery (within 1 month after stopping antibiotics for exacerbation)		Negative	4956	13.6							homozygous	F508del	F508del	5	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977219.SRR12184792	ECOCF0095, visit 6			V4	Human	GAZ:United States of America	Human	Lung	Bronchial tree and alveoli		ECOCF0095	Female	1/15/14	Bronchoalveolar lavage (BAL)	Exacerbation (no treatment)		Negative	4969	13.6							homozygous	F508del	F508del	6	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977218.SRR12184791	ECOCF0095, visit 7			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0095	Female	4/29/14	Sputum	Exacerbation (no treatment)	64	Negative	5073	13.9							homozygous	F508del	F508del	7	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977220.SRR12184790	ECOCF0097, visit 9			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0097	Male	1/28/14	Oral swab	Exacerbation (no treatment)		Negative	1518	4.2							other	2184IrsA+	G1244E	9	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977222.SRR12184789	ECOCF0098, visit 6			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0098	Male	5/20/14	Oral swab	Baseline	86	Negative	6398	17.5		N	N	N	N	Y				6	N	N	N	N	N	N	N	N	N	N	N	N	N																																									
SRS6977221.SRR12184788	ECOCF0020, visit 6			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0020	Female	3/17/14	Oral swab	Exacerbation (no treatment)		Negative	6210	17		N	N	N	N	N	other	W1282X	W1282X	6	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977223.SRR12184787	ECOCF0102, visit 5			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0102	Male	1/15/14	Oral swab	Exacerbation (no treatment)	95	Positive	6019	16.5		Y	Y	N	N	Y	other	W1282X	G542X	5	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977224.SRR12184786	ECOCF0102, visit 6			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0102	Male	1/23/14	Sputum	Exacerbation (treatment with antibiotics)		Positive	6027	16.5		Y	Y	N	N	Y	other	W1282X	G542X	6	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977225.SRR12184785	ECOCF0102, visit 7			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0102	Male	4/30/14	Oral swab	Baseline	77	Negative	6124	16.8		Y	Y	N	N	Y	other	W1282X	G542X	7	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977228.SRR12184782	ECOCF0104, visit 8			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0104	Male	12/18/13	Oral swab	Baseline		Negative	1635	4.5							heterozygous	F508del	Other	8	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977229.SRR12184781	ECOCF0104, visit 9			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0104	Male	3/13/14	Oral swab	Exacerbation (no treatment)		Positive	1720	4.7							heterozygous	F508del	Other	9	N	N	N	N	N	N	Y	N	N	N	Y	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977230.SRR12184780	ECOCF0104, visit 10			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0104	Male	5/13/14	Oral swab	Baseline		Negative	1781	4.9							heterozygous	F508del	Other	10	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977231.SRR12184779	ECOCF0105, visit 9			V4	Human	GAZ:United States of America	Human	Lung	Bronchial tree and alveoli		ECOCF0105	Male	1/8/14	Bronchoalveolar lavage (BAL)	Exacerbation (no treatment)		Positive	1666	4.6							heterozygous	F508del	Other	9	N	N	N	N	N	N	Y	N	N	N	Y	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977232.SRR12184778	ECOCF0105, visit 8			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0105	Male	12/18/13	Oral swab	Recovery (within 1 month after stopping antibiotics for exacerbation)		Negative	1645	4.5							heterozygous	F508del	Other	8	N	N	N	N	N	N	N	N	N	N	N	N	N																																									
SRS6977233.SRR12184777	ECOCF0108, visit 7			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0108	Female	2/11/14	Oral swab	Baseline		Negative	5776	15.8							heterozygous	F508del	A559T	7	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977234.SRR12184776	ECOCF0109, visit 7			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0109	Male	2/19/14	Oral swab	Recovery (within 1 month after stopping antibiotics for exacerbation)		Negative	6422	17.6		N	Y	N	N	Y	heterozygous	F508del	W1282X	7	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y
SRS6977235.SRR12184775	ECOCF0110, visit 7			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0110	Female	1/30/14	Oral swab	Exacerbation (no treatment)		Negative	2214	6.1		N	N	N	N	N	heterozygous	F508del	Other	7	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977237.SRR12184774	ECOCF0110, visit 8			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0110	Female	4/3/14	Oral swab	Baseline	101	Negative	2277	6.2		N	N	N	N	N	heterozygous	F508del	Other	8	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977236.SRR12184773	ECOCF0122, visit 8			V4	Human	GAZ:United States of America	Human	Respiratory tract		Sputum	ECOCF0122	Female	12/2/13	Sputum	Recovery (within 1 month after stopping antibiotics for exacerbation)	67	Negative	8279	22.7							heterozygous	F508del	N1303K	8	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977239.SRR12184771	ECOCF0122, visit 9			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0122	Female	1/31/14	Oral swab	Exacerbation (no treatment)		Negative	8339	22.8							heterozygous	F508del	N1303K	9	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977241.SRR12184770	ECOCF0128, visit 9			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0128	Female	1/31/14	Oral swab	Baseline		Negative	5624	15.4		Y	Y	N	N	Y	other	I507del	A559T	9	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977240.SRR12184769	ECOCF0128, visit 10			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0128	Female	3/11/14	Oral swab	Exacerbation (no treatment)		Positive	5663	15.5		Y	Y	N	N	Y	other	I507del	A559T	10	N	N	N	N	N	N	Y	N	N	N	Y	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	Y	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N	N
SRS6977242.SRR12184768	ECOCF0128, visit 11			V4	Human	GAZ:United States of America	Human	Oral cavity	Oropharynx		ECOCF0128	Female	4/4/14	Oral swab	Recovery (within 1 month after stopping antibiotics for exacerbation)	61	Negative	5687	15.6		Y	Y	N	N	Y	other	I507del	A559T	11	N	N	N	N	N	N	N	N	N	N	N	N	N																																									
SRS6977291.SRR12184719	ECOCF0128, visit 12			V4	Human	GAZ:United States of America	Human	Lung	Bronchial tree and alveoli		ECOCF0128	Female	4/15/14	Bronchoalveolar lavage (BAL)	Exacerbation (treatment with antibiotics)		Negative	5698	15.6		Y	Y	N	N	Y	other	I507del	A559T	12	N	N	N	N	N	N	N	N	N	N	N	N	N																																									
